FOREWORD
The Rules herein prescribed, and any amendments or additions thereto, apply to all persons, partnerships, associations, firms or corporations, their officers, directors, stockholders, agents, representatives or employees who hold, conduct, patronize, aid, assist or participate in any Race Meeting within the State of Arkansas where thoroughbred horse racing licensed by the State of Arkansas shall be permitted for any stake, purse or reward. The definitions and interpretations of racing terms herein set forth, as well as the Foreword, are to be considered in connection with the Rules and as a part of them.
In reading the Rules, unless the text otherwise requires, it shall be understood, without constant reference thereto, that they apply only in the State of Arkansas.
Every franchise to hold a Race Meeting is granted upon the condition that the franchise holder shall accept, observe and enforce said Rules. Furthermore, it shall be the duty of each and every officer, director and every official and employee of said franchise holder to observe and enforce the Rules.
Any and all of the Rules may be amended, altered, repealed or supplemented by new and additional Rules.
The Racing Commission shall have continuing jurisdiction and control over all penalties and decisions imposed or made by it, or its predecessors, except as otherwise provided by law. Furthermore, the Racing Commission shall have the power and authority to review, affirm, modify or rescind any penalty or decision with regard to any infraction of these Rules, which may be imposed or made by the racing officials of any Race Meeting.
The laws of the State of Arkansas and the Rules promulgated by the Racing Commission supersede the conditions of a race or the regulations of a Race Meeting.
Note: Numbering of these Rules will not be consecutive since the Racing Commission Rules that apply to other types of racing are omitted.
Absolute Insurer | 1233 |
Act 12 Purse and Construction Fund | 2500 |
Added Money, definition | 1002 |
Advance Deposit Wagering | 2800 |
Age, definition | 1003 |
Allowance Race, definition | 1005 |
Also Eligible, definition | 1004 |
Also-Eligibles and Preferred Lists | 2279-2289 |
Anabolic Steroids | 1217.1 (see appendix) |
Anti-Ulcer Medications | 1232 |
Appeal to Commission, definition | 1006 |
Appeals to Racing Commission | 1256-1260 |
Application for Dates | 1100, 1103-1104 |
Application for Franchises | 1101 |
Arrears, definition | 1007 |
Association Grounds, definition | 1009 |
Association, definition | 1008 |
Authorized Agent, definition | 1010 |
Authorized Agents | 2140-2146 |
Bar Plates | 1213 |
Beneficial Interest, definition | 1011 |
Betting Interest, definition | 1012 |
Bleeder List, definition | 1013 |
Breakage, definition | 1014 |
Breeder, definition | 1015 |
Cancellation, Races | 2274-2278 |
Carryover, definition | 1016 |
Claim of Foul and Protest | 2357-2371 |
Claiming | 2426-2458 |
Claiming - Revocation of Claims for EPO Positives | 2434 |
Claiming Race, definition | 1017 |
Classix | 2460 |
Clerk of Scales | 2003-2006 |
Coggins | 1269 |
Commission Chemist | 1235-1243 |
Commission Clocker | 2099 |
Commission Veterinarian | 1266-1268 |
Commission, Appeals to | 1256-1260 |
Commission, definition | 1018 |
Complaints | 1251 |
Conditions, definition | 1019 |
Contest, definition | 1020 |
Contestant, definition | 1021 |
Corporate Owners | 2137-2139 |
Coupled Entry, definition | 1022 |
Daily Double | 2424 |
Dates, Application for | 1100, 1103-1104 |
Day, definition | 1023 |
Dead Heat, definition | 1024 |
Dead Heats | 2381-2386 |
Dead Heats | 2423 |
Declaration and Scratches | 2267-2273 |
Declaration, definition | 1025 |
Disqualification, Term | 1245 |
Divided or Split Races | 2239 |
Drugs, Uniform Classifications & Guidelines | 1217 (see appendix) |
Drug Testing, Horses | 1235-1243 |
Drug Testing - Out of Competition Testing for Blood and/or Gene Doping Agents | 1217.2 (see appendix) |
Entry | 2212-2262 |
Entry, definition | 1026 |
Entry, Ineligible Horse | 1204 |
Equipment Changes | 2265-2266 |
Evidence, Substantial, definition | 1087 |
Exacta | 2424.1 |
Exhibition Race, definition | 1027 |
Expired Ticket, definition | 1028 |
Extracorpeal Shock Wave Treatment or Radial Pulse Wave Therapy | 1217.3 (see appendix) |
Felony Convictions | 1121 |
Field, definition | 1046 |
Financial Interest, definition | 1029 |
Fines | 1254, 1255 |
Finish Order, definition | 1051 |
Flat Race, definition | 1030 |
Forfeit, definition | 1031 |
Franchises, Application for | 1101 |
Furosemide | 1232 |
Guest Association, definition | 1032 |
Handbooks | 1118 |
Handicap Race, definition | 1033 |
Handle, definition | 1034 |
Horse disqualification, Term | 1245 |
Horse, definition | 1035 |
Horse, Tattoo | 2224 |
Horseshoes, Bar Plates | 1213 |
Horseshoes | 1211 |
Host Association, definition | 1036 |
Ineligible Horse, Entry of | 1204 |
Ineligibility of Horses Testing Positive for Blood Doping Agents | 1245(A), 2263 |
Ineligible Horse, Transfer | 1210 |
Inquiry, definition | 1037 |
Instant Racing Purse and Awards | 2700 |
Intra-Articular Joint Injections | 1272 |
Jockey Agent | 2179-2190 |
Jockey Apprentice | 2200-2202 |
Jockey, definition | 1038 |
Jockey, Mount Fees | 2169 |
Jockey, Naming of | 2176-2177 |
Jockey, Protective Headgear | 2163 |
Jockey, Safety Vest | 2163 |
Jockey, Riding Crop | 2163 |
Jockey, Suspension | 2171-2173 |
Jockeys | 2157-2175 |
Jockey's Room Custodian | 2011-2018 |
Lasix | 1232 |
License Prohibitions | 2111 |
License Revocation | 2109 |
License, Veterinarians | 2112 |
Licensee, definition | 1039 |
Licenses, Registrations, Fees | 2103-2114 |
Maiden Race, definition | 1041 |
Maiden, definition | 1040 |
Match Race, definition | 1043 |
"Milkshake" Rule | 1231 |
Minimum Payout, Minus Pool | 2419 |
Minus Pool | 2425 |
Minus Pool, definition | 1044 |
Minus Pool, Minimum Payout | 2419 |
Month, definition | 1045 |
Mutuel Field, definition | 1046 |
Mutuels, Classix | 2460 |
Mutuels, Daily Double | 2424 |
Mutuels, Dead Heats | 2423 |
Mutuels, Exacta | 2424.1 |
Mutuels, General | 2387-2419 |
Mutuels, Minus Pool | 2425 |
Mutuels, Pick 3 | 2461 |
Mutuels, Place Pool | 2421 |
Mutuels, Quinella | 2463 |
Mutuels, Show Pool | 2422 |
Mutuels, Superfecta | 2465 |
Mutuels, Trifecta | 2462 |
Mutuels, Win Pool | 2420 |
Mutuels, Wrong Ticket | 2416 |
Net Pool, definition | 1047 |
Nomination, definition | 1048 |
Nominator, definition | 1049 |
Objection, definition | 1050 |
Off Time, definition | 1054 |
Official Order of Finish, definition | 1051 |
Official Starter, definition | 1052 |
Official Starter | 2034-2060 |
Official Time, definition | 1053 |
Optional Claiming Race, definition | 1055 |
Outs | 1152 |
Outstanding Ticket, definition | 1056 |
Overnight Race, definition | 1057 |
Owner, definition | 1058 |
Owners | 2117-2132 |
Paddock Judge | 2019-2022 |
Paddock to Post | 2331-2345 |
Paddock, definition | 1059 |
Paddock, Restricted Area | 1140 |
Pari-mutuel Manager, Authority | 2417 |
Pari-mutuel System, definition | 1060 |
Pari-mutuel, General | 2387-2419 |
Partnerships | 2134-2136 |
Patron, definition | 1061 |
Payoff, definition | 1062 |
Performance, definition | 1063 |
Permit, definition | 1064 |
Person, definition | 1065 |
Photo-finish | 1149 |
Physical Inspection of Horses | 1271 |
Pick 3 | 2461 |
Pick 4 | 2466 |
Pick 5 | 2467 |
Place Pool | 2421 |
Place wagering, Drop | 2389 |
Placing Judge | 2025 |
Post Position | 2290-2291 |
Post Position, definition | 1066 |
Post Time, definition | 1067 |
Post to Finish | 2347-2356 |
Postmortem Examination | 1270 |
Preferred and Also-Eligibles Lists | 2279-2289 |
Prima Facie Evidence, definition | 1068 |
Profit Split, definition | 1070 |
Profit, definition | 1069 |
Program Trainers | 2224 |
Program, definition | 1071 |
Prohibited Practice, Use of Narcotics | 1234 |
Prohibited Practices, Administration of Drug | 1218 |
Prohibited Practices, Appliances | 2128 |
Prohibited Practices, Commission Employees | 1200 |
Prohibited Practices, Electrical Devices | 1214 |
Prohibited Practices, Extracorporeal Shock Wave Therapy or Radial Pulse Wave Therapy | 1217.3 (see appendix) |
Prohibited Practices, Franchise Holders | 1110 |
Prohibited Practices, Hypodermic Equipment | 1215 |
Prohibited Practices, Jockeys | 1205-1209 |
Prohibited Practices, Language and Conduct | 1247 |
Prohibited Practices, Racing Officials | 1201-1202 |
Prohibited Practices, Soliciting Bets | 1120 |
Prohibited Practices, Substances | 1216 |
Prohibited Practices, Tampering With Horse | 1212 |
Prohibited Practices, Track Veterinarian | 1261 |
Protest and Claim of Foul | 1072 |
Purse and Construction Fund | 2500 |
Purse Distribution | 1151 |
Purse, definition | 1073 |
Purse, Distribution | 2260 |
Purse, Redistribution | 1221 |
Quick Official | 2363 |
Quinella | 2463 |
Race Commission, Access | 1115 |
Race Meeting, definition | 1043 |
Race, definition | 1074 |
Race, Interference | 2347 |
Race, Jostle | 2348 |
Race, Strike Another Horse | 2349 |
Races, Cancellation of | 2274-2278 |
Racing Secretary, Handicapper | 2007-2010, 2026-2032 |
Reciprocity | 1122--1138 |
Registered Arkansas Bred, definition | 1075 |
Restricted Area, definition | 1076 |
Result, definition | 1077 |
Ruled Off | 1122-1138 |
Scale of Weight | 2313 |
Schooling or Starter's List | 2050-2054 |
Scratch, definition | 1078 |
Scratches and Declarations | 2267-2273 |
Shoes, Bar Plates | 1213 |
Shoes, | 1211 |
Show Pool | 2422 |
Show wagering, Drop | 2389 |
Simulcast, definition | 1080 |
Simulcasting | 1119 |
Split or Divided Races | 2239 |
Stable Name, definition | 1082 |
Stable Names | 2147-2156 |
Stakes, Distribution | 2260 |
Starter or Schooling List | 2050-2054 |
Starter, definition | 1052 |
Starter, definition | 1084 |
Starters, Maximum Number | 2258 |
Starters, Preference | 2258 |
Steward, definition | 1086 |
Stewards | 2061-2094 |
Stewards, Authority for Drug Testing | 2069 |
Stewards, Authority to Examine | 2074 |
Stewards, Authority to Exclude or Eject | 2071 |
Stewards, Authority to Fine or Rule Off | 1248 |
Stewards, Authority to Fine or Rule Off | 1253 |
Stewards, Authority to Suspend and Disqualify | 2070 |
Stewards, Determination of Claim of Foul | 2366 |
Stewards, Drug Testing | 2114 |
Stewards, Experience | 2061 |
Stewards, Hearings | 2094 |
Substantial Evidence, definition | 1087 |
Superfecta | 2465 |
Suspension and Ruled Off | 1122-1138 |
Takeout, definition | 1088 |
Tattoo | 2224 |
Testing, Horses | 1235-1243 |
Timing | 2095-2098 |
Total Dissolved Carbon Dioxide Testing ("Milkshake") | 1231 |
Totalisator | 1148 |
Totalisator, definition | 1089 |
Track Superintendent | 2100-2102 |
Track Veterinarian | 1261-1265 |
Track Veterinarian List | 1264 |
Trainer, Absolute Insurer | 1233 |
Trainers | 2117-2132 |
Trainers, Program Trainers | 2224 |
Treatment Records | 2133 |
Trifecta | 2462 |
Turn-downs | 1211 |
Valets | 2175 |
Vet's List | 1264 |
Walkover, definition | 1091 |
Week, definition | 1092 |
Weigh In, definition | 1093 |
Weighing In | 2314-2323 |
Weighing Out | 2324-2329 |
Weight for Age, definition | 1095 |
Weight Out, definition | 1094 |
Weight Penalties and Allowances | 2292-2312 |
Weight, Scale of | 2313 |
Win Pool | 2420 |
Winner, definition | 1096 |
Winnings | 2374-2379 |
Workout Requirement / Physical Examination | 2099 |
Workouts, First Time Starters | 2099 |
Wrong Ticket | 2416 |
Year, definition | 1097 |
Wagering Rules and Electronic Games of Skill (EGS) Rules are contained in a separate volume at the Commission Office.
DEFINITIONS
FRANCHISES AND APPLICATIONS FOR RACING DATES
APPLICATIONS FOR FRANCHISES
(If the applicant has a parent corporation, the same information must be submitted both for the parent and applicant corporation.)
This can be indicated in columnar forms as follows:
APPLICATIONS FOR RACING DATES
(If the applicant has a parent corporation, the same information must be submitted both for the parent and applicant corporation.)
Any information submitted after April 1, 1970, may reference information previously submitted under an application.
DUTIES AND OBLIGATIONS
CORRUPT, FRAUDULENT AND PROHIBITED PRACTICES
Racing officials shall include those officials who are approved and designated by the Racing Commission as racing officials for each live Race Meeting.
If the franchise holder so prohibits the administration of furosemide to horses entered in any of the above-referenced races, such race shall be referred to as a "Lasix-free Race." With respect to any horse participating in a Lasix-free Race, it shall constitute a violation of this Rule 1232(5) if the horse's post-race sample of urine, serum or plasma tests positive for furosemide at any level of detection indicating use within the 48-hour period prior to the Lasix-free Race. Such violation shall be deemed to constitute a violation under Penalty Category "B" of the ARCI Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule set forth in Rule 1217.5 in the Appendix to these Rules, with resulting consequences and penalties to the horse, owner and trainer as set forth therein for Penalty Category "B" violations.
In any case not provided for by this Rule with regard to the issuance of subpoenas, the law of Arkansas with regard to subpoenas issued by the Circuit Courts of this State shall apply.
TRACK VETERINARIAN
COMMISSION VETERINARIAN
ANIMAL HEALTH
The cost of Commission-ordered postmortem examinations, testing and disposal shall be borne by the Commission.
Unless otherwise directed by the Commission or Stewards, the functions set forth in subsection 5(e) of this rule shall be performed by the Track Veterinarian.
RULES FOR THOROUGHBRED RACING OFFICIALS & DUTIES
CLERK OF SCALES
HANDICAPPER
JOCKEY ROOM
PADDOCK JUDGE
PLACING JUDGES
RACING SECRETARY
OFFICIAL STARTER
STEWARDS
Any person acting as a Steward at Oaklawn Park shall have the following minimum qualifications:
METHOD OF TIMING
COMMISSION CLOCKER
TRACK SUPERINTENDENT
LICENSES, REGISTRATIONS AND FEES FOR PARTICIPANTS IN RACING
Owner | $60.00 |
Partnership | $60.00 |
Stable Name | $60.00 |
Trainer/Asst. Trainer | $55.00 |
Jockey/App. Jockey/Jockey Agent | $55.00 |
Veterinarian | $45.00 |
Authorized Agent | $38.00 |
Horseshoer | $35.00 |
Employee | $ 5.00 |
Stable Names | $20.00 |
Partnership or Corporation | 20.00 |
The identification system for licensed personnel shall consist of:
OWNERS AND TRAINERS
PARTNERSHIPS
All partnership papers must be signed by all of the parties or by their authorized agents.
CORPORATE AND LLC OWNERS
AUTHORIZED AGENTS
STABLE NAMES
JOCKEYS
The safety vest shall weigh no more than two (2) pounds and shall not be included in a jockey's weight when weighing out to race. If a jockey fails to wear a safety vest in the running of any race, the jockey's horse shall be disqualified. The Stewards or Racing Commission may levy additional penalties or fines against the jockey or trainer.
PURSE | WINNING MOUNT | SECOND MOUNT | THIRD MOUNT | FOURTH MOUNT | LOSING MOUNTS |
Purses up to $24,999 | 10% of win purse | 5% of place purse, or $110, whichever is greater | 5% of show purse, or $100, whichever is greater | $90 | $80 |
$25,000- 49,999 | 10% of win purse | 5% of place purse | 5% of show purse | 5% of fourth place purse or $95, whichever is greater | $85 |
$50,000- 99,999 | 10% of win purse | 5% of place purse | 5% of show purse | 5% of fourth place purse | $95 |
$100,000 to $999,999 | 10% of win purse | 5% of place purse | 5% of show purse | 5% of fourth place purse | $120 |
$1,000,000 and up | 10% of win purse | 5% of place purse | 5% of show purse | 5%of fourth place purse | $250 |
NAMING OF JOCKEYS
JOCKEY AGENT
JOCKEY APPRENTICES
A temporary apprentice license may be issued by the Stewards upon notification of the recommendation of the approval board.
After riding in an adequate number of races, and when the stewards are satisfied that the applicant has demonstrated competence in his/her abilities to ride in races, a regular apprentice license will then be issued.
ENTRIES
EQUIPMENT CHANGES
DECLARATIONS AND SCRATCHES
POSTPONEMENT AND CANCELLATION OF RACES
PREFERRED AND ALSO ELIGIBLE LISTS
POST POSITION
WEIGHT PENALTIES AND ALLOWANCES
WEIGHT, SCALE OF
Distance | Age Years | March and April | May | June | July | Aug. | Sept. | Oct. | Nov. & Dec. |
3 years | 115 | 116 | 117 | 119 | 121 | 123 | 124 | 125 | |
Half | 4 years | 126 | 126 | 126 | 126 | 126 | 126 | 126 | 126 |
Mile | 5 & over | 126 | 126 | 126 | 126 | 126 | 126 | 126 | 126 |
3 years | 116 | 119 | 120 | 122 | 123 | 125 | 126 | 127 | |
Six | 4 year | 130 | 130 | 130 | 130 | 130 | 130 | 130 | 130 |
Furlongs | 5 & over | 132 | 132 | 132 | 130 | 130 | 130 | 130 | 130 |
3 years | 109 | 112 | 114 | 116 | 118 | 119 | 120 | 120 | |
One | 4 years | 128 | 127 | 126 | 126 | 126 | 126 | 126 | 126 |
Mile | 5 & over | 130 | 129 | 128 | 126 | 126 | 126 | 126 | 126 |
One Mile | 3 years | 106 | 108 | 112 | 114 | 117 | 118 | 120 | 120 |
and a | 4years 128 | 127 | 126 | 126 | 126 | 126 | 126 | 126 | |
Quarter | 5 & over | 130 | 129 | 128 | 126 | 126 | 126 | 126 | 126 |
One and | 3 years | 103 | 105 | 107 | 110 | 116 | 118 | 119 | 120 |
a Half | 4 years | 127 | 127 | 126 | 126 | 126 | 126 | 126 | 126 |
Miles | 5 & over | 130 | 129 | 128 | 126 | 126 | 126 | 126 | 126 |
3 years | 100 | 102 | 104 | 108 | 112 | 114 | 117 | 118 | |
Two | 4 years | 127 | 126 | 126 | 126 | 125 | 125 | 124 | 124 |
Miles | 5 & over | 130 | 129 | 128 | 126 | 125 | 125 | 124 | 124 |
3 years | 97 | 99 | 100 | 102 | 107 | 108 | 110 | 112 | |
Three | 4 years | 127 | 127 | 127 | 126 | 126 | 126 | 124 | 122 |
Miles | 5 & over | 130 | 129 | 128 | 126 | 126 | 125 | 124 | 122 |
Footnotes.
WEIGHING IN
WEIGHING OUT
PADDOCK TO POST
POST TO FINISH
PROTESTS
WINNINGS
DEAD HEATS
MUTUELS
STEPS IN CALCULATING THE PAYOFF IN WIN POOL
STEPS IN CALCULATING THE PAYOFF IN A PLACE POOL
STEPS IN CALCULATING THE PAYOFF IN A SHOW POOL
STEPS IN CALCULATING THE PAYOFF IN DEAD HEATS
DAILY DOUBLE
EXACTA WAGERING
MINUS POOL
CLAIMING
CLAIMING AUTHORIZATION:
However, notwithstanding the foregoing, a Claiming Authorization may not be issued to any thoroughbred horse trainer licensed as such in any jurisdiction unless the trainer is a member of a partnership, limited liability company, corporation or other entity that would otherwise be eligible for a Claiming Authorization and the claim is being made by that partnership, limited liability company, corporation or other entity.
All claims shall be deposited in the claiming box at least fifteen (15) minutes before the established post time of the race out of which the claim is made.
OAKLAWN JOCKEY CLUB CLASSIX RULES
In the event that any number of races less six comprising the Classix are completed, one hundred percent (100%) of the net pool for the Classix shall be distributed among holders of pari-mutuel tickets that designate the most winners in the completed races. No carryover from a previous day shall be added to the Classix pool in which less than six races have been completed. Any net pool carryover accrued from a previous Classix feature shall be further carried over to the next scheduled Classix Pool operated by Oaklawn.
PICK-3 WAGERING
Trifecta Wager
Quinella Wager
SUPERFECTA POOL
PICK-4 WAGERING
Pick 5 Wagering
Instant Racing #5, Instant Double
PURSE, CONSTRUCTION AND PATRONAGE AND TOURISM PROMOTION FUND
Instant Racing Purse & Awards
Advance Deposit Wagering.
APPENDIX
within twenty-four (24) hours prior to the scheduled post time of the race the horse is running except furosemide as provided for in this rule. The prohibitions in this section include, but are not limited to, injection or jugging of vitamins, electrolyte solutions, and amino acid solutions. The prohibition also includes, but is not limited to, the topical, oral, or nasal administration of compounds, such as Traileze, Vapol, Vicks vapor-rub, windaid, exhale ease, or containing methylsalicylate, camphor, potassium iodide, or products containing "caine" derivatives or dimethylsulfoxide (DMSO).
Furosemide may be administered intravenously to a horse, which is entered to compete in a race. Except under the instructions of the commission veterinarian or the racing veterinarian for the purpose of removing a horse from the veterinarian's list or to facilitate the collection of a post- race urine sample, furosemide shall be permitted only after the commission veterinarian has placed the horse on the furosemide list. In order for a horse to be placed on the furosemide list, the following process must be followed:
A horse that bleeds from its nostrils, but upon endoscopic examination shows no sign of pulmonary hemorrhage, shall not be subject to the restrictions imposed by this section. After expiration of the ineligibility period, a horse must perform a workout without bleeding, to the satisfaction of the commission veterinarian. Prior to the workout, a blood sample may be collected by the Commission veterinarian and sent to the commission's testing laboratory. After the workout, the commission veterinarian may witness an endoscopic examination of the horse to confirm the horse has not bled.
No person shall tamper with, adulterate, add to, break the seal of, remove, or otherwise attempt to so alter or violate any sample required to be collected by this rule, except for the addition of preservatives or substances necessarily added by the commission approved laboratory for preservation of the sample or in the process of analysis.
Laboratories providing split sample testing shall be RMTC accredited unless otherwise approved by the commission. The request must be in writing, include the laboratory selection, and must be delivered to the stewards not later than ninety-six (96) hours after the trainer has received notice of a positive test result. Failure to request testing of a split sample and provide all necessary information within ninety-six (96) hours shall constitute a waiver of the right. The split sample laboratory shall be contacted by a representative of the commission to request acceptance of a split sample. The trainer or owner may choose any laboratory on the commission maintained applicable list to test the sample. However, the commission or executive director may limit the choice of laboratory for the detection of specific drugs.
Anabolic Steroids
Androgenic-Anabolic Steroids (AAS)
Out of Competition Testing for Blood and/or Gene Doping Agents
Prohibited Practices - Extracorporeal Shock Wave Therapy or Radial Pulse Wave Therapy
Multiple Medication Violations (MMV)
Penalty Class Controlled | Points If Controlled Therapeutic Substance | Points If Non Substance |
Class A | N/A | 6 |
Class B | 2 | 4 |
Class C | 1/2 for first violation with | 1 for first violation |
with | an additional 1/2 point for | an additional 1/2 |
point for | each additional violation | each additional |
violation | within 365 days1 | within 365 days |
Class D | 0 | 0 |
If the Stewards or Commission determine that the violation is due to environmental contamination, they may assign lesser or no points against the trainer based upon the specific facts of the case.
1Points for NSAID violations only apply when the primary threshold of the NSAID is exceeded. Points are not to be separately assigned for a stacking violation.
Points | Suspension in days |
5-5.5 | 15 to 30 |
6-8.5 | 30 to 60 |
9-10.5 | 90 to 180 |
11 or more | 180 to 360 |
MMV penalties are not a substitute for the current penalty system and are intended to be an additional uniform penalty when the licensee:
The Stewards and Commission shall consider aggravating and mitigating circumstances, including the trainer's prior record for medication violations, when determining the appropriate penalty for the underlying offense. The MMV is intended to be a separate and additional penalty for a pattern of violations.
Penalty Classification | Time to Expire |
A | 3 years |
B | 2 years |
C | 1 year |
In the case of a medication violation that results in a suspension, any points assessed expire on the anniversary date of the date the suspension is completed.
Uniform Classification Guidelines for Foreign Substances and Recommended Penalties
DRUG TESTING STANDARDS AND PRACTICES PROGRAM.
Uniform Classification Guidelines for Foreign Substances And Recommended Penalties Model Rule.
December, 2020 (V.14.4)
© ASSOCIATION OF RACING COMMISSIONERS INTERNATIONAL - 2020.
Association of Racing Commissioners International
2365 Harrodsburg Road, Suite B-450, Lexington, Kentucky USA 40504 www.arci.com
Preamble to the Uniform Classification Guidelines of Foreign Substances
The Preamble to the Uniform Classification Guidelines was approved by the RCI Drug Testing and Quality Assurance Program Committee (now the Drug Testing Standards and Practices Program Committee) on August 26, 1991. Minor revisions to the Preamble were made by the Drug Classification subcommittee (now the Veterinary Pharmacologists Subcommittee) on September 3, 1991.
"The Uniform Classification Guidelines printed on the following pages are intended to assist stewards, hearing officers and racing commissioners in evaluating the seriousness of alleged violations of medication and prohibited substance rules in racing jurisdictions. Practicing equine veterinarians, state veterinarians, and equine pharmacologists are available and should be consulted to explain the pharmacological effects of the drugs listed in each class prior to any decisions with respect to penalities to be imposed. The ranking of drugs is based on their pharmacology, their ability to influence the outcome of a race, whether or not they have legitimate therapeutic uses in the racing horse, or other evidence that they may be used improperly. These classes of drugs are intended only as guidelines and should be employed only to assist persons adjudicating facts and opinions in understanding the seriousness of the alleged offenses. The facts of each case are always different and there may be mitigating circumstances which should always be considered. These drug classifications will be reviewed frequently and new drugs will be added when appropriate."
Notes Regarding Classification Guidelines
* Where the use of a drug is specifically permitted by a jurisdiction, then the jurisdiction's rule supersedes these penalty guidelines.
* Regulators should be aware that a laboratory report may identify a drug only by the name of its metabolite. The metabolite might not be listed here, but the parent compound may be.
* These classes of drugs are intended only as guidelines and should be employed only to assist persons adjudicating facts and opinions in understanding the seriousness of the alleged offenses.
* The facts of each case are different and there may be mitigating circumstances that should be considered.
* These drug classifications will be reviewed periodically. New drugs will be added or some drugs may be reclassified when appropriate.
* Racing Commissioners International (RCI) and/or the Racing Medication and Testing Consortium (RMTC) should be consulted for found substances or drugs not included in these guidelines and treated as Class 1 violations warranting a Class A penalty unless otherwise advised.
Classification Criteria
The RCI Drug Classification Scheme is based on 1) pharmacology, 2) drug use patterns, and 3) the appropriateness of a drug for use in the racing horse. Categorization is decided using the following general guidelines:
* Pharmacology. Drugs that are known to be potent stimulants or depressants are placed in higher classes, while those that have (or would be expected to have) little effect on the outcome of a race are placed in lower classes.
* Drug Use Patterns. Some consideration is given to placement of drugs based on practical experience with their use and the nature of positive tests. For example, procaine positives have in the past been associated primarily with the administration of procaine penicillin, and this has been taken into consideration in the placement of procaine into Class 3 instead of Class 2 with other injectable local anesthetics.
* Appropriateness of Drug Use. Drugs that clearly are intended for use in equine therapeutics are placed in lower classes. Drugs that clearly are not intended for use in the horse are placed in higher classes, particularly if they might affect the outcome of a race. Drugs that are recognized as legitimately useful in equine therapeutics but could affect the outcome of a race are placed in the middle or higher classes.
The list includes most drugs that have been reported as detected by racing authority laboratories in the United States, Canada, the United Kingdom and other Association of Official Racing Chemists (AORC) laboratories, but does not include those which would seem to have no effect on the performance of the horse or drug detectability. For example, it does not include antibiotics, sulfonamides, vitamins, anthelmintics, or pangamic acid, all of which have been reported.
The list contains many drugs that have never been reported as detected. Usually, these are representatives of chemical classes that have the potential for producing an effect, and in many cases, for which at least one drug in that chemical class has been reported.
Most drugs have numerous effects, and each was judged on an individual basis. There are instances where there is a rather fine distinction between drugs in one category and those in the next. This is a reflection of a nearly continuous spectrum of effects from the most innocuous drug on the list to the drug that is the most offensive.
Classification Definitions
* Class 1: Stimulant and depressant drugs that have the highest potential to affect performance and that have no generally accepted medical use in the racing horse. Many of these agents are Drug Enforcement Agency (DEA) schedule II substances. These include the following drugs and their metabolites: Opiates, opium derivatives, synthetic opioids and psychoactive drugs, amphetamines and amphetamine-like drugs as well as related drugs, including but not limited to apomorphine, nikethamide, mazindol, pemoline, and pentylenetetrazol. Though not used as therapeutic agents, all DEA Schedule 1 agents are included in Class 1 because they are potent stimulant or depressant substances with psychotropic and often habituative actions. This class also includes all erythropoietin stimulating substances and their analogues.
* Class 2: Drugs that have a high potential to affect performance, but less of a potential than drugs in Class 1. These drugs are 1) not generally accepted as therapeutic agents in racing horses, or 2) they are therapeutic agents that have a high potential for abuse. Drugs in this class include: psychotropic drugs, certain nervous system and cardiovascular system stimulants, depressants, and neuromuscular blocking agents. Injectable local anesthetics are included in this class because of their high potential for abuse as nerve blocking agents.
* Class 3: Drugs that may or may not have generally accepted medical use in the racing horse, but the pharmacology of which suggests less potential to affect performance than drugs in Class 2. Drugs in this class include bronchodilators, anabolic steroids and other drugs with primary effects on the autonomic nervous system, procaine, antihistamines with sedative properties and the high-ceiling diuretics.
* Class 4: This class includes therapeutic medications that would be expected to have less potential to affect performance than those in Class 3. Drugs in this class includes less potent diuretics; corticosteroids; antihistamines and skeletal muscle relaxants without prominent central nervous system (CNS) effects; expectorants and mucolytics; hemostatics; cardiac glycosides and anti-arrhythmics; topical anesthetics; antidiarrheals and mild analgesics. This class also includes the non-steroidal anti-inflammatory drugs (NSAIDs), at concentrations greater than established limits.
* Class 5: This class includes those therapeutic medications that have very localized actions only, such as anti-ulcer drugs, and certain anti-allergic drugs. The anticoagulant drugs are also included.
* Prohibited Practices:
Drug Classification Scheme
* Class 1: Opiates, opium derivatives, synthetic opioids, psychoactive drugs, amphetamines, and all DEA Schedule I substances (see http://www.deadiversion.usdoj.gOv/schedules/#list). and many DEA Schedule II drugs. Also found in this class are drugs that are potent stimulants of the CNS. Drugs in this class have no generally accepted medical use in the racing horse and their pharmacologic potential for altering the performance of a racing horse is very high. This class also includes all erythropoietin stimulating substances and their analogues.
* Class 2: Drugs placed in this category have a high potential for affecting the outcome of a race. Most are not generally accepted as therapeutic agents in the racing horse. Many are products intended to alter consciousness or the psychic state of humans, and have no approved or indicated use in the horse. Some, such as injectable local anesthetics, have legitimate use in equine medicine, but should not be found in a racing horse. The following groups of drugs are placed in this class:
* Class 3: Drugs placed in this class may or may not have an accepted therapeutic use in the horse. Many are drugs that affect the cardiovascular, pulmonary and autonomic nervous systems. They all have the potential of affecting the performance of a racing horse. The following groups of drugs are placed in this class:
* Class 4: Drugs in this category comprise primarily therapeutic medications routinely used in racehorses. These may influence performance, but generally have a more limited ability to do so. Groups of drugs assigned to this category include the following:
* Class 5: Drugs in this category are therapeutic medications that have very localized actions only, such as anti-ulcer drugs, and certain antiallergic drugs. The anticoagulant drugs are also included.
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
[TRIANGLE]-1-androstene-3,17diol | 3 | A | |||
[TRIANGLE]-1-androstene-3, 17dione | 3 | A | |||
[TRIANGLE]-1-dihydrotestosterone | 3 | A | |||
1-androstenediol (5aandrost-1-ene-3[BETA], 17[BETA]diol) | 3 | B | Steroid - endogenous weak androgen steroid hormone and intermediate in the biosynthesis of testosterone from dehydroepiandrosterone (DHEA) and of estrone. | Endogenous AAS | |
1-androstenedione (5aandrost-1-ene-3, 17dione) | 3 | B | Steroid - endogenous weak androgen steroid hormone and intermediate in the biosynthesis of testosterone from dehydroepiandrosterone (DHEA) and of estrone. | Endogenous AAS | |
1-testosterone (17[BETA]hydroxy-5a-androst-len-3-one) | 3 | A | Steroid - chemically related to anabolic steroids. | AAS lacking EDA approval | |
19-Norandrostenediol | 3 | B | |||
19-Norandrostenedione | 3 | B | |||
19-noretiocholanolone. | 3 | B | Nandrolene Link - a metabolite of nandrolone (19-nortestosterone) and bolandione (19norandrostenedione). | Metabolite of a B substance | |
2-Aminoheptane | Tuamine | 4 | B | ||
3-Methoxytyramine | 3-MT | 2 | A | ||
3,4-methylenedioxypyprova krone | MDPV, "bath salts" | 1 | A | ||
4-androstene-3,6,l 7 trione (6-oxo) | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Aromatase inhibitors. | Testolactone has B classification | |
4-androstenediol (androst-4-ene-3[BETA],17[BETA]diol) | 3 | B | Testosterone Link - androstenediol that is converted to testosterone. | Metabolized to a B substance | |
4-Hydroxytestosterone | 3 | B | |||
5-androstenedione (androst-5- ene-3,17dione) | 3 | B | Testosterone Link - prohormone of testosterone. | Metabolized to a B substance | |
5[ALPHA]-androstane-3a,17adiol | 3 | B | Testosterone Link - testosterone metabolite. | Metabolite of a B substance | |
5[ALPHA]-androstane-3[ALPHA],17[BETA]diol | 3 | B | Testosterone Link - testosterone metabolite. | Metabolite of a B substance | |
5[ALPHA]-androstane-3[BETA],17[ALPHA]diol | 3 | B | Testosterone Link - testosterone metabolite. | Metabolite of a B substance | |
5[ALPHA]-androstane-3[BETA],17[BETA]diol | 3 | B | Testosterone Link - testosterone metabolite. | Metabolite of a B substance | |
5[BETA]-androstane-3 [ALPHA], 17[BETA]diol, androst-4-ene3[ALPHA],17[ALPHA]diol | 3 | B | Testosterone Link - androstenediol that is converted to testosterone. | Metabolized to a B substance | |
7-keto-dhea;19- | 3 | B | DHEA Link - a steroid produced by metabolism of the prohormone dehydroepiandrosterone (DHEA). | Metabolite of a B substance | |
7[ALPHA]-hydroxy-dhea | 3 | B | DHEA Link - naturally occurring steroid and a major metabolite of dehydroepiandrosterone (DHEA). | Metabolite of a B substance | |
7[BETA]-hydroxy-dhea | 3 | B | DHEA Link - naturally occurring steroid and a major metabolite of dehydroepiandrosterone (DHEA). | Metabolite of a B substance | |
a-Cobratoxin | 1 | A | |||
Acebutolol | Sectral | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Acecarbromal | 2 | A | |||
Acenocoumarol | 5 | C | |||
Acepromazine | Atrovet, Noten.sil, PromAce® | 3 | B | ||
Acetaminophen (Paracetamol) | Tylenol, Tempra, etc. | 4 | C | ||
Acetanilid | 4 | B | |||
Acetazolamide | Diamox, Vetamox | 4 | C | ||
Acetophenazine | Tindal | 2 | A | ||
Acetophenetidin (Phenacetin) | 4 | B | |||
Acetylcysteine | 4 | C | |||
Acetylsalicylic acid (Aspirin) | 4 | C | |||
Activators of the AMPactivated protein kinase (AMPK) - E.g., A ICAR, and Peroxisome Proliferator A ctivated Receptor [DELTA] (ppar[DELTA]) agonists (e.g., GW 1516). | MCAR | 2 | A | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines. | PPARs are experimental drugs without FDA approval |
Adinazolam | 2 | A | |||
Adrenochrome monosemicarbazone salicylate | 4 | B | |||
Albuterol (Salbutamol) | Proventil, Ventolin | 3 | B | NOTE: "A" penalty for quarter horse races. | |
Alclofenac | 2 | B | |||
Alclometasone | Aclovate | 4 | C | ||
Alcuronium | Alloferin | 2 | A | ||
Aldosterone | Aldocortin, Electrocortin | 4 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Alfentanil | Alfenta | 1 | A | ||
Almotriptan | Axert | 3 | A | ||
Alphaprodine | Nisentil | 2 | A | ||
Alpha-pyrrolidinovalerophenone (also known as Alpha PVP) | 1 | A | Known as bath salts in humans | ||
Alpidem | Atiaxyl | 2 | A | ||
Alprazolam | Xanax | 2 | A | ||
Alprenolol | Saffan | 2 2 | A A | ||
Althesin | |||||
Altrenogest | Regumate | 4 | C | *Classification for geldings, colts, adult intact males, spayed females only. | |
Amhenonium | Mytelase, Myeuran | 3 | B | ||
Amhroxol | Ambril, etc. | 4 | B | ||
Ameinonide | Cyclocort | 4 | C | ||
Amiloride | Moduretic; Midamor | 4 | B | ||
Aminocaproic acid | Amicar, Caprocid | 4 | C | ||
Amino glutethimide | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines. | Testolactone has B classification | |
Aminophylline | Aminophyllin, etc. | 3 | B | ||
Aminopyrine | 4 | B | |||
Aminorex | Aminoxafen, Aminoxaphen, Apiquel, McN-742, Menocil | 1 | A | ||
Amiodarone | 4 | B | |||
Amisometradine | Rolictron | 4 | B | ||
Amisulpride | Solian | 2 | A | ||
Amitraz | Mitaban | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Amitriptyline | Elavil, Amitril, Endep | 2 | A | ||
Amlodipine | Ammivin, Norvasc | 3 | B | ||
Amobarbital | Amytal | 2 | A | ||
Amoxapine | Asendin | 2 | A | ||
Amperozide | 2 | A | |||
Amphetamine | 1 | A | |||
Amrinone | 4 | B | |||
Amyl nitrite | 2 | A | |||
Anastrozole | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Aromatase inhibitors. | Testolactone has B classification | |
Andarine | 2 | A | SARM | ||
Androst-4-ene-3[ALPHA],17[BETA]diol | 3 | B | Testosterone Link - an androstenediol that is converted to testosterone. | Metabolized to a B substance | |
Androst-4-ene-3[BETA]diol,17[ALPHA]diol | 3 | B | Testosterone Link - an androstenediol that is converted to testosterone. | Metabolized to a B substance | |
Androst-5-ene-3[ALPHA],17[ALPHA]diol | 3 | B | Testosterone Link - androstenediol that is converted to testosterone. | Metabolized to a B substance | |
Androst-5-ene-3[ALPHA], 17[BETA]diol | 3 | B | Testosterone Link - prohormone of testosterone. | Metabolized to a B substance | |
Androst-5-ene-3[BETA]diol,17[ALPHA]diol | 3 | B | Testosterone Link - prohormone of testosterone. | Metabolized to a B substance | |
Androsta-1,4,6-triene-3,17-dione (androstatrienedione) | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Aromatase inhibitors. | Testolactone has B classification |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Androstenediol (androst-5-ene-3[BETA], 17[BETA]diol) | 3 | B | Steroid: weak androgen and estrogen steroid hormone and intermediate in the biosynthesis of testosterone from dehydropiandrosterone (DHEA) | Metabolite of a B substance | |
Androstenedione (androst-4-ene-3, 17dione) | 3 | B | Steroid: endogenous weak androgen steroid hormone and intermediate in the biosynthesis of testosterone from dehydroepiandrosterone (DHEA) and of estrone. | Endogenous AAS | |
Androsterone (3[BETA]hydroxy-5 [ALPHA]-androstan-17-one) | 3 | B | Testosterone Link - a metabolite of testosterone and dihydrotestosterone (DHT). | Metabolite of a B substance | |
Anileridine | Leritine | 1 | A | ||
Anilopam | Anisine | 2 | A | ||
Anisindione | 5 | D | |||
Anisotropine | Valpin | 4 | B | ||
Antipyrine | 4 | B | |||
Apazone (Azapropazone) | Rheumox | 4 | B | ||
Apomorphine | 1 | A | |||
Aprindine | 4 | B | |||
Aprobarbital | Alurate | 2 | A | ||
ARA-290 | 1 | A | Erythropoietin Link - a nonerythropoietic peptide engineered from erythropoietin. | Blood doping agent | |
Arecoline | 3 | A | |||
Arformoterol | 3 | B | |||
Aripiprazole | Abilfy | 2 | A | ||
Arsenic | 3 | B | Arsenic is present in pressure-treated lumber designated for non-residential use. Cribbing or wood chewing may result in expsoure sufficient to result in concentrations in excess of the screening limit. Findings for arsenic warrant investigation into the route of exposure with mitigation to 3/C recommended when there is compelling evidence for environmental exposure rather than deliberate administration. |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Aromatase inhibitors listed: | |||||
Articaine | Septocaine; Ultracaine, | 2 | B | ||
Asialo EPO | 1 | A | Erythropoietin Link - desialylated form of human glycoprotein hormone erythropoietin (EPO), which has been reported to be neuro-, cardio-, and renoprotective in animal models of organ injuries. | Blood doping agent | |
Atenolol | Tenormin | 3 | B | ||
Atipamazole | 2 | B | |||
Atomoxetine | Strattera | 2 | A | ||
Atracurium | Tracrium | 2 | A | ||
Atropine | 3 | B | |||
Azacylonol | Frenque | 2 | A | ||
Azaperone | Stresnil, Suicalm, Fenta: (with Fentanyl) | 2 | A | ||
Baclofen | Lioresal | 4 | B | ||
Barbital | Veronal | 2 | A | ||
Barbiturates | 2 | A | |||
Beclomethasone | Propaderm | 4 | C | ||
Bemegride | Megimide, Mikedimide | 2 | A | ||
Benazepril | Lotrel, Lotensin | 3 | A | ||
Bendroflumethiazide | Naturetin | 4 | B | ||
Benoxaprofen | 2 | B | |||
Benoxinate | Dorsacaine | 4 | C |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Benperidol | Anquil | 2 | A | ||
Bentazepam | Tiadipona | 2 | A | ||
Benzactizine | Deprol, Bronchodiletten | 2 | A | ||
Benzocaine | 4 | B | |||
Benzoctamine | 2 | A | |||
Benzodiazepines | 2 | A | |||
Benzonatate | Tessalon, Tessalon Perles, Zonatuss | 2 | A | ||
Benzphetamine | Didrex | 2 | A | ||
Benzthiazide | 4 | B | |||
Benztropine | Cogentin | 2 | A | ||
Benzylpiperazine (BZP) | 1 | A | |||
Bepridil | Bepadin | 4 | B | ||
Betamethasone | Betasone, etc. | 4 | C | ||
Betaxolol | Kerlone | 3 | B | ||
Bethanechol | Urecholine, Devoid | 4 | C | ||
Bethanidine | Esbatal | 3 | A | ||
Biperiden | Akineton | 3 | A | ||
Biriperone | 2 | A | |||
Bisoprolol | Zebeta, Bisobloc, etc. | 3 | B | ||
Bisphosphonates (any) | 3 | A | |||
Bitolterol | Effectin | 3 | A | ||
Bolandiol (estr-4-ene3[BETA], 17[BETA]-diol) | 3 | A | Steroid | AAS lacking FDA approval |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Bolasterone | 3 | A | |||
Boldenone | Equipoise | 3 | B | ||
Boldione | 3 | A | |||
Botulinum toxin | 2 | A | |||
Bretylium | Bretylol | 3 | B | ||
Brimonidine | Alphagan | 2 | A | ||
Bromazepam | Lexotan, Lectopam | 2 | A | ||
Bromfenac | Duract | 3 | A | ||
Bromhexine | Oletor, etc. | 4 | B | ||
Bromisovalum | Diffucord, etc. | 2 | A | ||
Bromocriptine | Parlodel | 2 | A | ||
Bromo diphenhydramine | 3 | B | |||
Bromperidol | Bromidol | 2 | A | ||
Brompheniramine | Dimetane, Disomer | 3 | B | ||
Brotizolam | Brotocol | 2 | A | ||
Budesonide | Pulmacort, Rhinocort | 4 | C | ||
Bufexamac | 3 | A | |||
Bumetanide | Bumex | 3 | B | ||
Bupivacaine | Marcaine | 2 | A | ||
Buprenorphine | Temgesic | 2 | A | ||
Bupropion | Wellbutrin | 2 | A | ||
Buspirone | Buspar | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Butabarbital (Secbutobarbitone) | Butacaps, Butasol, etc. | 2 | A | ||
Butacaine | Butyn | 2 | A | ||
Butalbital (Talbutal) | Fiorinal | 2 | A | ||
Butamben (butyl aminobenzoate) | Butesin | 4 | C | ||
Butanilicaine | Hostacain | 2 | A | ||
Butaperazine | Repoise | 2 | A | ||
Butoctamide | Listomin | 2 | A | ||
Butorphanol | Stadol, Torbugesic | 3 | B | ||
Butoxycaine | Stadacain | 4 | B | ||
Caffeine | 2 | B | |||
Calusterone | Methosorb | 3 | A | ||
Camazepam | Paxor | 2 | A | ||
Camphor | 4 | C | |||
Candesartan | Atcand | 3 | B | ||
Cannabidiol (CBD)1 | Anti-epileptic, analgesic | 2 | B | ||
Canrenone | 4 | C | Metabololite of a C substance - steroidal antimineralocorticoid, active metabolite of spironolactone (a diuretic). | ||
Capsaicin | 2 | B | |||
Captodiame | Covatine | 2 | A | ||
Captopril | Capolen | 3 | B | ||
Carazolol | Carbacel, Conducton | 3 | A | ||
Carbachol | Lentin, Doryl | 3 | B | ||
Carbamezapine | Tegretol | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Carbamylated EPO | 1 | A | Erythropoietin Link - may be a beneficial tissueprotective cytokine. | Blood doping agent | |
Carbazochrome | 4 | B | |||
Carbidopa + levodopa | Sinemet | 2 | A | ||
Carbinoxamine | Clistin | 3 | B | ||
Carbromol | Mifudorm | 2 | A | ||
Cardarine (GW-501516) | 2 | A | No legit use in the racehorse. Lacks FDA approval | ||
Carfentanil | 1 | A | |||
Carisoprodol | Rela, Soma | 2 | B | ||
Carphenazine | Proketazine | 2 | A | ||
Carpipramine | Prazinil | 2 | A | ||
Carprofen | Rimadyl | 4 | B | ||
Carteolol | Cartrol | 3 | B | ||
Carticaine (see articaine) | Septocaine; Ultracaine, etc. | 2 | B | ||
Carvedilol | Coreg | 3 | B | ||
Cathinone | khat, kat, qat. quat, chat, catha, Abyssinian tea, African tea | 1 | A | ||
Celecoxib | Celebrex | 3 | B | ||
Cetirizine | Zyrtec | 4 | C | ||
Chloral betaine | Beta-Chlor | 2 | A | ||
Chloral hydrate | Nactec, Oridrate, etc. | 2 | A | ||
Chloraldehyde (chloral) | 2 | A | |||
Chloralose (AlphaChloralose) | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Chlordiazepoxide | Librium | 2 | A | ||
Chlorhexidol | 2 | A | |||
Chlormerodrin | Neohydrin | 4 | B | ||
Chlormezanone | Trancopal | 2 | A | ||
Chloroform | 2 | A | |||
Chlorophenesin | Maolate | 4 | C | ||
Chloroprocaine | Nesacaine | 2 | A | ||
Chloroquine | Avloclor | 4 | C | ||
Chlorothiazide | Diuril | 4 | B | ||
Chlorpheniramine | Chlortriemton, etc. | 4 | B | ||
Chlorproethazine | Newiplege | 2 | A | ||
Chlorpromazine | Thorazine, Largactil | 1 | A | ||
Chlorprothixene | Taractan | 2 | A | ||
Chlorthalidone | Hydroton | 4 | B | ||
Chlorzoxazone | Paraflex | 4 | B | ||
Chorionic Gonadotropin (CG) | 3 | B | Hormone and behavioral effects - a water soluble glycoprotein derived from human pregnancy urine. Used for behavior modification in colts / horses. There should be no restriction/regulation in fillies and mares. | ||
Ciclesonide | 4 | C | |||
Cilostazol | Pletal | 4 | B | ||
Cimeterol | 3 | A | |||
Cimetidine | Tagamet | 5 | D | ||
Cinchocaine | Nupercaine | 2 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Citalopram | Celex | 2 | A | ||
Clanobutin | 4 | B | |||
Clemastine | Tavist | 3 | B | ||
Clenbuterol | Ventipubnin | 3 | B | NOTE: "A" penalty for quarter horse races. | |
Clibucaine | Batrax | 2 | A | ||
Clidinium | Quarezan, Clindex, etc. | 3 | B | ||
Clobazam | Urbanyl | 2 | A | ||
Clobetasol | Temovate | 4 | C | ||
Clocapramine | 2 | A | |||
Clocortolone | Cloderm | 4 | C | ||
Clodronate | OsPhos | 3 | A | Bisphosphonate | |
Clofenamide | 4 | B | |||
Clomethiazole (Chlormethiazole) | 2 | A | |||
Clomiphene | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Estrogen modulator. | Testolactone has B classification | |
Clomipramine | Ancfranil | 2 | A | ||
Clonazepam | Klonopin | 2 | A | ||
Clonidine | Catapres | 3 | B | ||
Clorazepate | Tranxene | 2 | A | ||
Clormecaine | Placacid | 2 | A | ||
Clostebol | 3 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Clothiapine | Entermin | 2 | A | ||
Clotiazepam | Trecalmo, Rize | 2 | A | ||
Cloxazolam | Enadel, Sepazon, Tolestan | 2 | A | ||
Clozapine | Clozaril, Leponex | 2 | A | ||
CNTO 530 | 1 | A | Erythropoietin Link - a biopharmaceutical consisting of a novel peptide that mimics the actions of erythropoietin, CNTO 530 produced sustained increases in red blood cell parameters. | Blood doping agent | |
Cobalt (check note) | 3 | B1 | For cobalt concentrations of less than 25 parts per billion (ppb) of blood serum or plasma no penalty is recommended. For concentrations of 25 ppb or greater but less than 50 ppb of blood plasma or serum the recommended penalty is a written warning, the placement of the horse on the Veterinarians List with removal from list only after a blood test confirms that the concentration is below 25 ppb of blood plasma or serum. Testing shall be paid by the owner(s) of the horse. Concentrations of 50 ppb or greater in blood plasma or serum have a recommended "B" penalty. | ||
Cocaine | 1 | A3 | If it is determined by the State Veterinarian/Equine Medical Director; the Stewards, or the Racing Authority that the finding of cocaine or morphine was unintentional and not based upon an attempt to affect the outcome of a race, the Stewards or Racing Authority may elect to assign a Class B penalty to the trainer. | ||
Codeine | 1 | A | |||
Colchicine | 4 | B | |||
Conorphone | 2 | A | |||
Corticaine | Ultracain | 2 | A | ||
Corticotrophind | 3 | B | Peptide hormone involved in the stress response. | ||
Cortisone | Cortone, etc. | 4 | C | ||
Cromolyn | Intel | 5 | D |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Crotetamide | 2 | A | |||
Cyamemazine | Tercian | 2 | A | ||
Cyclandelate | Cyclospasmol | 3 | A | ||
Cyclizine | Merazine | 3 | B | ||
Cyclobarbital | Phanodorm | 2 | A | ||
Cyclobenzaprine | Flexeril | 4 | B | ||
Cyclofenil | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - selective estrogen receptor modulator (SERM). | Testolactone has B classification | |
Cyclomethycaine | Sinfacaine | 4 | C | ||
Cyclothiazide | Anhydron, Renazide | 4 | B | ||
Cycrimine | Pagitane | 3 | B | ||
Cyproheptadine | Periactin | 3 | B | ||
Danazol | Danocrine | 3 | B | ||
Dantrolene | Dantrium | 4 | C | ||
Darbepoetin | Aranesp | 1 | A | ||
Darbepoetin (depo) | 1 | A | Erythropoietin Link - Bone marrow stimulant (Erythropoiesisstimulating agents are medications which stimulates the bone marrow to make red blood cells). | Blood doping agent | |
Decamethonium | Syncurine | 2 | A | ||
Dehydrochloromethylte stosterone | 3 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Dembroxol (Dembrexine) | Sputolysin | 4 | C | ||
Demoxepam | 2 | A | |||
Deoxycorticosterone | Percortin, DOCA, Descotone, Dorcostrin | 4 | C | ||
Deracoxib | Deremaxx | 3 | B | ||
Dermorphin | 1 | A | |||
Desipramine | Norpromine, Pertofrane | 2 | A | ||
Desonide | Des Owen | 4 | c | ||
Desoximetasone | Topicort | 4 | c | ||
Desoxymethyltestosterone | 3 | A | |||
Detomidine | Dormosedan | 3 | B | ||
Dexamethasone | Azium, etc. | 4 | C | ||
Dextromethorphan | 4 | B | |||
Dextromoramide | Palfium, Narcolo | 1 | A | ||
Dextropropoxyphene | Darvon | 3 | B | ||
Dezocine | Dalgan | 2 | A | ||
Diamorphine | 1 | A | |||
Diazepam | Valium | 2 | B | ||
Diazoxide | Proglycem | 3 | B | ||
Dibucaine | Nupercainal, Cinchocaine | 2 | B | ||
Dichloralphenazone | Febenol, Isocom | 2 | A | ||
Dichlorphenamide | Daramide | 4 | C | ||
Diclofenac | Voltaren, Voltarol | 4 | C |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Dicumarol | Dicumarol | 5 | D | ||
Diethylpropion | Tepanil, etc. | 2 | A | ||
Diethylthiambutene | Themalon | 2 | A | ||
Diflorasone | Florone, Max,flor | 4 | c | ||
Diflucortolone | Flu-Cortinest, etc. | 4 | c | ||
Diflunisal | 3 | B | |||
Digitoxin | Crystodigin | 4 | B | ||
Digoxin | Lanoxin | 4 | B | ||
Diisopropylamine | 2 | B | Consistent with nitroglycerine | ||
Dihydrocodeine | Parcodin | 2 | A | ||
Dihydroergotamine | 4 | B | |||
Dihydrotestosterone (17[BETA]-hydroxy-5aandrostan-3-one) | 3 | B | Steroid - endogenous androgen sex steroid and hormone. | Endogenous AAS | |
Dilorazepam | Briantum | 2 | A | ||
Diltiazem | Cardizem | 4 | B | ||
Dimefline | 3 | A | |||
Dimethisoquin | Quotane | 4 | B | ||
Dimethylsulfoxide (DMSO) | Domoso | 4 | C | ||
Diphenadione | 5 | C | |||
Diphenhydramine | Benadryl | 3 | B | ||
Diphenoxylate | Difenoxin, Lomotil | 4 | B | ||
Diprenorphine | M50/50 | 2 | A | ||
Dipyridamole | Persantine | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Dipyrone | Novin, Methampyrone | 4 | c | ||
Disopyramide | Norpace | 4 | B | ||
Divalproex | Depakote | 3 | A | ||
Dixyrazine | Esucos | 2 | A | ||
Dobutamine | Dobutrex | 3 | B | ||
Donepezil | Aricept | 1 | A | ||
Dopamine | Intropin | 2 | A | ||
Doxacurium | Nuromax | 2 | A | ||
Doxapram | Dopram | 2 | A | ||
Doxazosin | 3 | A | |||
Doxefazepam | Doxans | 2 | A | ||
Doxepin | Adapin, Sinequan | 2 | A | ||
Doxylamine | Decapryn | 3 | B | ||
Dromostanolone | Drolban | 3 | B | ||
Droperidol | Inapsine, Droleptan, Innovar-Vet (with Fentanyl) | 2 | A | ||
Drostanolone | 3 | A | Steroid | AAS lacking FDA approval | |
Duloxetine | 2 | A | |||
Dyclonine | Dyclone | 4 | C | ||
Dyphylline | 3 | B | |||
Edrophonium | Tensilon | 3 | B | ||
Eletripan | Relpax | 3 | A | ||
Eltenac | 4 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Enalapril (metabolite enaloprilat) | Vasotec | 3 | A | ||
Enciprazine | 2 | A | |||
Endorphins | 1 | A | |||
Enkephalins | 1 | A | |||
Ephedrine | 2 | A | |||
Epidihydrotestosterone | 3 | B | Testosterone Link - androgenic metabolite of testosterone. | Metabolite of a B substance | |
Epibatidine | 2 | A | |||
Epinephrine | 2 | A | |||
Epitestosterone | 3 | B | Testosterone Link - endogenous steroid and an epimer of the androgen sex hormone testosterone. | Endogenous, stereoisomer of a B substance. | |
EPO-Fc | 1 | A | Erythropoietin Link - fusion protein in human blood. | Blood doping agent | |
EPO-mimetic peptides (EMP): | 1 | A | |||
Ergoloid mesylates (dihydroergocornine mesylate, dihydroergocristine mesylate, and dihydroergocryptine mesylate) | 2 | A | |||
Ergonovine | Ergotrate | 4 | C | ||
Ergotamine | Gynergen, Cafergot, etc. | 4 | B | ||
Erthrityl tetranitrate | Cardilate | 3 | A | ||
Erythropoietin (EPO) | Epogen, Procrit, etc. | 1 | A | ||
Esmolol | Brevibloc | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Esomeprazole | Nexium | 5 | D | ||
Estazolam | Domnamid, Eurodin, Nuctalon | 2 | A | ||
Eszopiclone | 2 | A | |||
Etacrynic acid | 3 | C | |||
Etamiphylline | 3 | B | |||
Etanercept | Enbrel | 4 | B | ||
Ethacrynic acid | Edecrin | 3 | B | ||
Ethamivan | 2 | A | |||
Ethanol | 2 | A | |||
Ethchlorvynol | Placidyl | 2 | A | ||
Ethinamate | Vahnid | 2 | A | ||
Ethoheptazine | Zactane | 2 | A | ||
Ethopropazine | Parsidol | 2 | A | ||
Ethosuximide | Zarontin | 3 | A | ||
Ethotoin | Peganone | 4 | B | ||
Ethoxzolamide | Cardrase, Ethamide | 4 | C | ||
E thy laminob enzo ate (Benzocaine) | Semets, etc. | 4 | C | ||
Ethylestrenol | Maxibolin, Organon | 3 | B | ||
Ethylisobutrazine | Diquel | 2 | A | ||
Ethylmorphine | Dionin | 1 | A | ||
Ethylnorepinephrine | Bronkephrine | 3 | A | ||
Ethylphenidate | 1 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Etidocaine | Duranest | 2 | A | ||
Etifoxin | Stresam | 2 | A | ||
Etiocholanolone | 3 | B | Testosterone Link - etiocholane steroid as well as an endogenous 17-ketosteroid that is produced from the metabolism of testosterone. | Metabolite of a B substance | |
Etizolam | Depas, Pasaden | 2 | A | ||
Ethamsylate | 4 | B | |||
Etodolac | Lodine | 3 | B | ||
Etodroxizine | Indunox | 2 | A | ||
Etofenamate | 4 | B | Consistent with other nonFDA approved NSAIDs | ||
Etomidate | 2 | A | |||
Etorphine HC1 | M99 | 1 | A | ||
Exemestane | Aromatase inhibitors | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Aromatase inhibitors. | Testolactone has B classification |
Famotidine | Gaster, etc. | 5 | D | ||
Felbamate | Felbatol | 3 | B | ||
Felodipine | Plendil | 4 | B | ||
Fenarbamate | Tymium | 2 | A | ||
Fenbufen | Cincopal | 3 | B | ||
Fenclozic acid | Myalex | 2 | B | ||
Fenfluramine | Pondimin | 2 | A | ||
Fenoldopam | Corlopam | 3 | B | ||
Fenoprofen | Nalfon | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Fenoterol | Berotec | 3 | B | ||
Fenspiride | Respiride, Respan, etc | 3 | B | ||
Fentanyl | Sublimaze | 1 | A | ||
Fentiazac | 3 | B | |||
Fexofenadine | Allegra | 4 | C | ||
Fibroblast Growth Factors (fgfs), Hepatocyte Growth Factor (HGF), Insulinlike Growth Factor-1 (IGF-1) and its analogues, Mechano Growth Factors (mgfs), Platelet-Derived Growth Factor (PDGF), V ascular-Endothelial Growth Factor (VEGF) and any other growth factor affecting muscle, tendon or ligament protein synthesis/ degradation, vascularization, energy utilization, regenerative capacity or fiber type switching. | 3 | A | Cardiac, Muscle effects - a family of peptide cytokines that are important in the regulation of many tissues. | Lack FDA approval; no legitimate use in race horse. | |
Firocoxib | 4 | C | |||
Flecainide | Idalon | 4 | B | ||
Floctafenine | Idalon, Idarac | 4 | B | ||
Fluanisone | Sedalande | 2 | A | ||
Fludiazepam | Erispam | 2 | A | ||
Fludrocortisone | Aforone, etc. | 4 | C | ||
Flufenamic acid | 4 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Flumethasone | Flucort, etc. | 4 | C | ||
Flumethiazide | Ademol | 4 | B | ||
Flunarizine | Sibelium | 4 | B | ||
Flunisolide | Bronilide, etc. | 4 | C | ||
Flunitrazepam | Rohypnol, Narcozep, Darkene, Hypnodorm | 2 | A | ||
Flunixin | Banamine | 4 | C* | ||
Fluocinolone | Synalar | 4 | C | ||
Fluocinonide | Licon, Lidex | 4 | C | ||
Fluopromazine | Psyquil, Siquil | 2 | A | ||
Fluoresone | Caducid | 2 | A | ||
FluoromethoIone | FML | 4 | C | ||
Fluoroprednisolone | 4 | B | |||
Fluoxetine | Prozac | 2 | A | ||
Fluoxymesterone | Halotestin | 3 | B | ||
Flupenthixol | Depixol, Fluanxol | 2 | A | ||
Fluphenazine | Prolixin, Permitil, Anatensol, etc. | 2 | B | ||
Flupirtine | Katadolone | 3 | A | ||
Fluprednisolone | Alphadrol | 4 | C | ||
Flurandrenolide | Cordran | 4 | C | ||
Flurazepam | Dalmane | 2 | A | ||
Flurbiprofen | Froben | 3 | B | ||
Fluspirilene | Imap, Redeptin | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Fluticasone | Flixonase, Flutide | 4 | C | ||
Flutoprazepam | Restas | 2 | A | ||
Fluvoxamine | Dumirox, Faverin, etc. | 2 | A | ||
Formebolone | 3 | A | |||
Formestane | Aromatase inhibitors | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Aromatase inhibitors. | Testolactone has B classification |
Formoterol | Altram | 3 | B | ||
Fosinopril | Monopril | 3 | A | ||
Fosphenytoin | Cerebyx | 3 | B | ||
Fulvestrant | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Estrogen receptor antagonist antineoplastic agent. | Testolactone has B classification | |
Furazabol | 3 | A | |||
Furosemide | Lasix | N/A | |||
Gabapentin | Neurontin | 3 | B | ||
Galantamine | Reminyl | 2 | A | ||
Gallamine | Flaxedil | 2 | A | ||
Gamma Aminobutryic Acid (GABA) | Carolina Gold | 3 | B | ||
Gepirone | 2 | A | |||
Gestrinone | 3 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
GH-Releasing Peptides (ghtps), e.g., alexamorelin, GHRP-6, hexarelin and pralmorelin (GHRP-2) | 3 | A | Anabolic Effects - a synthetic GH secretagogue. | Anabolic agent lacking FDA approval | |
Glutethimide | Doriden | 2 | A | ||
Glycopyrrolate | Robinul | 4 | C | ||
Growth Hormone Releasing Hormone (GHRH) and its analogues, e.g., CJC-1295, sermorelin and tesamorelin | 3 | A | Anabolic Effects - peptide analogue of growth hormone-releasing hormone which is used as a diagnostic agent to assess growth hormone secretion for the purpose of diagnosing growth hormone deficiency. | Anabolic agent lacking FDA approval | |
Growth Hormone Secretogogues (GHS), e.g., ghrelin and ghrelin mimetics, e.g., anamorelin and ipamorelin | 3 | A | Anabolic Effects - hunger hormone, appetiteenhancing and anabolic effects. | Anabolic agent lacking FDA approval | |
Guaifenesin (glycerol guiacolate) | Gecolate | 4 | C | ||
Guanabenz | Wytensin | 3 | B | ||
Guanadrel | Hylorel | 3 | A | ||
Guanethidine | Ismet in | 3 | A | ||
Halazepam | Paxipam | 2 | A | ||
Halcinonide | Halog | 4 | C | ||
Halobetasol | Ultravate | 4 | C | ||
Haloperidol | Haldol | 2 | A | ||
Haloxazolam | Somelin | 2 | A | ||
Harpagoside | 4 | B | Devil's Claw Plant |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Hemoglobin glutamers | Oxyglobin Hemopure | 2 | A | ||
Heptaminol | Corefundol | 3 | B | ||
Heroin | 1 | A | |||
Hexafluorenium | Myalexen | 2 | A | ||
Hexobarbital | Evipal | 2 | A | ||
Hexocyclium | Tral | 4 | B | ||
Hexylcaine | Cyclaine | 2 | B | ||
HIF activators (e.g. Argon, xenon) | 3 | A | Cardiovascular Effects - a key mediator of oxygen homeostasis that was first identified as a transcription factor that is induced and activated by decreased oxygen tension. | Blood doping agent | |
Homatropine | Homapin | 3 | B | ||
Homophenazine | Pelvichthol | 2 | A | ||
Hydralazine | Apresoline | 3 | B | ||
Hydrochlorthiazide | Hydrodiuril | 4 | B | ||
Hydrocodone (dihydrocodienone) | Hycodan | 1 | A | ||
Hydrocortisone (Cortisol) | Cortef, etc. | 4 | C | ||
Hydroflumethiazide | Saluron | 4 | B | ||
Hydromorphone | Dilaudid | 1 | A | ||
Hydroxy amphetamine | Paradrine | 1 | A | ||
Hydroxyzine | Atarax | 2 | B | ||
Hypoxia-inducible factor (HIF) activators | 1 | A | Blood doping agent | ||
Hypoxia-inducible factor (HIF) stabilizers (e.g. IOX-2) | 1 | A | Blood doping agent | ||
Ibomal | Noctal | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Ibuprofen | Motrin, Advil, Nutpin, etc. | 4 | C | ||
Ibutilide | Convert | 3 | B | ||
Iloprost | Ventavis | 3 | A | ||
Imipramine | Imavate, Presamine, Tcfranil | 2 | A | ||
Indapamide | Diuretic | 3 | C | ||
Indomethacin | Indocin | 3 | B | ||
Infliximab | Remicade | 4 | B | ||
Insulins | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - protein hormone that is used as a medication to treat high blood sugar. | ||
Ipratropium | 3 | B | |||
Irbesarten | Avapro | 3 | A | ||
Isapirone | 2 | A | |||
Isocarboxazid | Marplan | 2 | A | ||
Isoetharine | Bronkosol | 3 | B | ||
Isoflupredone | Predef 2x | 4 | c | ||
Isomethadone | 2 | A | |||
Isometheptene | Octin, Octon | 4 | B | ||
Isopropamide | Darbid | 4 | B | ||
Isoproterenol | Iscprel | 2 | A | ||
Isosorbide dinitrate | Isordil | 3 | B | ||
Isoxicam | Maxicam | 2 | B | ||
Isoxsuprine | Vasodilan | 4 | D | ||
Isradipine | DynaCirc | 4 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Kebuzone | 3 | B | |||
Ketamine | Ketalar, Ketaset, Vetalar | 2 | B | ||
Ketazolam | Anxon, Leftram, Solatran, Lcftran | 2 | A | ||
Ketoprofen | Orudis | 4 | C* | ||
Ketorolac | Toradol | 3 | A | ||
Labetalol | Normodyne | 3 | B | ||
Lamotrigine | Lamictal | 3 | A | ||
Lansoprazole | 5 | D | |||
Lenperone | Elanone-V | 2 | A | ||
Letosteine | Viscotiol, Visiotal | 4 | B | ||
Letrozole | 3 | A | |||
Levamisole | 2 | B | |||
Levobunolol | Betagan | 3 | B | ||
Levomethorphan | 2 | A | |||
Levorphanol | Levo-Dremoran | 1 | A | ||
Lidocaine | Xylocaine | 2 | B | ||
Ligandrol | 2 | A | SARM | ||
Lisinopril | Prinivil, Zestril | 3 | A | ||
Lithium | Lithizine, Duralith, etc. | 2 | A | ||
Lobeline | 2 | A | |||
Lofentanil | 1 | A | |||
Loflazepate, Ethyl | Victan | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Loperamide | Imodium | 3 | B | ||
Loprazolam | Dormonort, Havlane | 2 | A | ||
Loratidine | Claritin | 4 | C | ||
Lorazepam | Ativan | 2 | A | ||
Lormetazepam | Noctamid | 2 | A | ||
Losartan | Hyzaar | 3 | B | ||
Loxapine | Laxitane | 2 | A | ||
Luteinizing Hormone (LH) | 3 | B | Hormone and behavioral effects - a hormone produced by gonadotropic cells in the anterior pituitary gland. In females, an acute rise of LH triggers ovulation and development of the corpus luteum. Used for behavior modification in colts / horses. There should be no restriction/regulation in fillies and mares. | ||
Mabuterol | 3 | A | |||
Maprotiline | Ludiomil | 2 | A | ||
Mazindol | Sanorex | 1 | A | ||
Mebutamate | Axiten, Dormate, Capla | 2 | A | ||
Mecamylamine | Inversine | 3 | B | ||
Meclizine | Antivert, Bonine | 3 | B | ||
Meclofenamic acid | Arquel | 4 | C | ||
Meclofenoxate | Lucidiril, etc. | 2 | A | ||
Medazepam | Nobrium, etc. | 2 | A | ||
Medetomidine | Damintor | 3 | B | ||
Medroxyprogesterone | 3 | B | Classification for all genders | ||
Medrysone | Medriusar, etc. | 4 | C | ||
Mefenamic acid | Ponstel | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Meldonium | Mildronate, etal | 1 | A | ||
Meloxicam | Mobic | 4 | B | ||
Melperone | Eunerpan | 2 | A | ||
Memantine | Namenda | 2 | A | ||
Meparfynol | Oblivon | 2 | A | ||
Mep azine | Pacatai | 2 | A | ||
Mepenzolate | Cantil | 3 | B | ||
Meperidine | Demerol | 1 | A | ||
Mephenesin | Tolserol | 4 | B | ||
Mephenoxalone | Control, etc. | 2 | A | ||
Mephentermine | Wy amine | 1 | A | ||
Mephenytoin | Mesantoin | 2 | A | ||
Mephobarbital (Methylphenobarbital) | Mebaral | 2 | A | ||
Mepivacaine | Carbocaine | 2 | B | ||
Meprobamate | Equanil, Miltown | 2 | A | ||
Meralluride | Mercuhydrin | 4 | B | ||
Merbaphen | Novasural | 4 | B | ||
Mercaptomerin | Thiomerin | 4 | B | ||
Mercumatilin | Cumertilin | 4 | B | ||
Mersalyl | Salyrgan | 4 | B | ||
Mesalamine | Asacol | 5 | C | ||
Mesoridazine | Serentil | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Mestanolone | 3 | A | |||
Mesterolone | 3 | A | |||
Metaclazepam | Tails | 2 | A | ||
Metandienone | 3 | A | Steroid | AAS lacking FDA approval | |
Metaproterenol | Alupent, Metaprel | 3 | B | ||
Metaraminol | Aram ine | 1 | A | ||
Metaxalone | Skelaxin | 4 | B | ||
Metazocine | 2 | A | |||
Metenolone | 3 | A | Steroid | AAS lacking FDA approval | |
Metformin | 2 | B | |||
Methacholine | 3 | A | |||
Methadone | Dolophine | 1 | A | ||
Methamphetamine | Desoxyn | 1 | A4 | Recommended Penalty B if testing can prove presence of only levo-methamphetamine is present in sample. | |
Methandriol (Methylandrostenediol) | Probolic | 3 | A | ||
Methandrostenolone | Dianobal | 3 | A | ||
Methantheline | Banthine | 3 | B | ||
Methapyrilene | Histadyl, etc. | 3 | B | ||
Methaqualone | Quaalude | 1 | A | ||
Metharbital | Gemonil | 2 | A | ||
Methasterone | 3 | A | |||
Methazolamide | Naptazane | 4 | C | ||
Methcathinone | 1 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Methdilazine | Tacaryl | 3 | B | ||
Methenolone | Primobolan | 3 | A | ||
Methixene | Trest | 3 | A | ||
Methocarbamol | Robaxin | 4 | c | ||
Methohexital | Brevital | 2 | A | ||
Methotrexate | Folex, Nexate, etc. | 4 | B | ||
Methotrimeprazine | Levcprome, Neurocil, etc. | 2 | A | ||
Methoxamine | Vasoxyl | 3 | A | ||
Methoxyphenamine | Orthoxide | 3 | A | ||
Methoxypolyethylene glycol-epoetin beta (CERA) | 1 | A | Erythropoietin Link - an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia associated with chronic kidney disease (CKD in adult patients on dialysis and patients not on dialysis. | Blood doping agent | |
Methscopolamine | Famine | 4 | B | ||
Methsuximide | Celontin | 4 | B | ||
Methyclothiazide | Enduron | 4 | B | ||
Methyl-l-testosterone | 3 | A | |||
Methylatropine | 3 | B | |||
Methyldienolone | 3 | A | |||
Methyldopa | Aldomet | 3 | A | ||
Methylergonovine | Methergine | 4 | C | ||
Methylhexanamine (Methylhexaneamine) | Geranamine | 1 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Methylnortestosterone (Trestolone) | 3 | A | |||
Methylphenidate | Ritalin | 1 | A | ||
Methylprednisolone | Medrol | 4 | c | ||
Methyltestosterone | Metandren | 3 | B | ||
Methyprylon | Noludar | 2 | A | ||
Methysergide | Sansert | 4 | B | ||
Metiamide | 4 | B | |||
Metoclopramide | Region | 4 | C | ||
Metocurine | Metubine | 2 | A | ||
Metolazone | 3 | B | |||
Metomidate | Hypnodil | 2 | A | ||
Metopon (methydihydromorphin one) | 1 | A | |||
Metoprolol | Lopressor | 3 | B | ||
Metribolone | 3 | A | Steroid | AAS lacking FDA approval | |
Mexazolam | Melex | 2 | A | ||
Mexiletine | Mexitil | 4 | B | ||
Mibefradil | Posicor | 3 | B | ||
Mibolerone | 3 | B | |||
Midazolam | Versed | 3 | B | ||
Midodrine | Pro-Amiline | 3 | B | ||
Milrinone | 4 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Minoxidil | Loniten | 3 | B | ||
Mirtazepine | Remeron | 2 | A | ||
Misoprostol | Cytotec | 5 | D | ||
Mitragynine | Kratom | 1 | A | ||
Mivacurium | Mivacron | 2 | A | ||
Modafinil | Provigil | 2 | A | ||
Moexipril (metabolite, moexiprilat) | Uniretic | 3 | B | ||
Molidustat | 1 | A | Blood doping agent | ||
Molindone | Moban | 2 | A | ||
Mometasone | Elocon | 4 | C | ||
Montelukast | Singulair | 4 | C | ||
Moperone | Luvatren | 2 | A | ||
Morphine | 1 | A6 | If it is determined by the State Veterinarian/Equine Medical Director; the Stewards, or the Racing Authority that the finding of cocaine or morphine was unintentional and not based upon an attempt to affect the outcome of a race, the Stewards or Racing Authority may elect to assign a Class B penalty to the trainer. | ||
Mosaprimine | 2 | A | |||
Muscarine | 3 | A | |||
myo-inositol trispyrophosphate (ITPP) | 1 | A | |||
N-Butylscopolamine | 4 | C | |||
Nabumetone | Anthraxan, Relafen, Reliflex | 3 | A | ||
Nadol | Corgard | 3 | B | ||
Naepaine | Amylsine | 2 | A | ||
Nalbuphine | Nubain | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Nalorphine | Nalline, Lethidrone | 2 | A | ||
Naloxone | Narcan | 3 | B | ||
Naltrexone | Revia | 3 | B | ||
Nandrolone | Nandrolin, Laurabolin, Durabolin | 3 | B | ||
Naphazoline | Privine | 4 | B | ||
Naproxen | Equiproxen, Naprosyn | 4 | C | ||
Naratriptan | Amerge | 3 | B | ||
Nebivolol | 3 | A | |||
Nedocromil | Tilade | 5 | D | ||
Nefazodone | Serzone | 2 | A | ||
Nefopam | 3 | A | |||
Neostigmine | Prostigmine | 3 | B | ||
Nicardipine | Cardine | 4 | B | ||
Nifedipine | Procardia | 4 | B | ||
Niflumic acid | Njluril | 3 | B | ||
Nikethamide | Coramine | 1 | A | ||
Nimesulide | 3 | B | |||
Nimetazepam | Erimin | 2 | A | ||
Nimodipine | Nemotop | 4 | B | ||
Nitrazepam | Mogadon | 2 | A | ||
Nitroglycerin | 2 | B | |||
Nizatidine | Axid | 5 | D |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Norandrosterone | 3 | B | Nandrolene Link - a detectable metabolite of nandrolone, an anabolic-androgenic steroid. | Metabolite of a B substance | |
Norbolethone/Norbolet one | 3 | A | |||
Norclostebol | 3 | A | |||
Nordiazepam | Calmday, Nordaz, etc. | 2 | A | ||
Norethisterone (norethindrone) | 4 | B all genders | No known use in the horse | ||
Norepinephrine | 2 | A | |||
Norethandrolone | 3 | A | |||
Nortestosterone | 3 | B | |||
Nortriptyline | Aventyl, Pamelor | 2 | A | ||
Nylidrine | Arlidin | 3 | A | ||
Olanzepine | Zyprexa | 2 | A | ||
Olicerdine | 1 | A | FDA approved opioid for humans | ||
Olmesartan | Benicar | 3 | A | ||
Olsalazine | Dipentum | 5 | c | ||
Omeprazole | Prilosec, Losec | 5 | D | ||
Oripavine | 2 | A | |||
Orphenadrine | Norlfex | 4 | B | ||
Ostarine | 2 | A | SARM | ||
Oxabolone | 3 | A | |||
Oxandrolone | Anavar | 3 | B | ||
Oxaprozin | Daypro, Deflam | 4 | B | ||
Oxazepam | Serax | 2 | A | ||
Oxazolam | Serenal | 2 | A | ||
Oxcarbazepine | Trileptal | 3 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Oxilofrine (hydroxyephedrine) | 2 | A | |||
Oxprenolol | Trasicor | 3 | A | ||
Oxycodone | Percodan | 1 | A | ||
Oxymesterone | 3 | A | |||
Oxymetazoline | Afrill | 4 | B | ||
Oxymetholone | Adroyd, Anadrol | 3 | B | ||
Oxymorphone | Numotphan | 1 | A | ||
Oxyperitine | Forit, Integrin | 2 | A | ||
Oxyphenbutazone | Tandearil | 4 | c | ||
Oxyphencyclimine | Daricon | 4 | B | ||
Oxyphenonium | Antrenyl | 4 | B | ||
Paliperidone | 2 | A | |||
Pancuronium | Pavulon | 2 | A | ||
Pantoprazole | Protonix | 5 | D | ||
Papaverine | Pavagen, etc. | 3 | A | ||
Parecoxib | 4 | B | |||
Paraldehyde | Paral | 2 | A | ||
Paramethadione | Paradione | 3 | A | ||
Paramethasone | Haldrone | 4 | C | ||
Pargyline | Eutonyl | 3 | A | ||
Paroxetine | Paxil, Seroxat | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Peginesatide | 1 | A | Erythropoietin Link - an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis. | Blood doping agent | |
Pemoline | Cylert | 1 | A | ||
Penbutolol | Levatol | 3 | B | ||
Penfluridol | Cyperon | 2 | A | ||
Pentaerythritol tetranitrate | Duotrate | 3 | A | ||
Pentazocine | Tahvin | 3 | B | ||
Pentobarbital | Nembutal | 2 | A | ||
Pentoxyfylline | Trental, Vazcfirin | 4 | D | ||
Pentylenetetrazol | Metrazol, Nioric | 1 | A | ||
Perazine | Taxilan | 2 | A | ||
Perfluorocarbons | 2 | A | |||
Perfluorodecahydronop hthalene | 2 | A | |||
Perfluorodecolin | 2 | A | |||
Perfluorooctylbromide | 2 | A | |||
Perfluorotripropylamine | 2 | A | |||
Pergolide | Permax | 3 | B | ||
Periciazine | Alodept, etc. | 2 | A | ||
Perindopril | Biprel | 3 | A | ||
Perlapine | Hypnodin | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Perphenazine | Trilafan | 2 | A | ||
Phenacemide | Phenurone | 4 | B | ||
Phenaglycodol | Acalo, Alcamid, etc. | 2 | A | ||
Phenazocine | Narphen | 1 | A | ||
Phencyclidine (PCP) | Sernylan | 1 | A | ||
Phendimetrazine | Bontril, etc. | 1 | A | ||
Phenelzine | Nardelzine, Nardil | 2 | A | ||
Phenindione | Hedulin | 5 | D | ||
Phenmetrazine | Prehtdin | 1 | A | ||
Phenobarbital | Luminal | 2 | A | ||
Phenoxybenzamine | Dibenzyline | 3 | B | ||
Phenprocoumon | Liquamar | 5 | D | ||
Phensuximide | Milontin | 4 | B | ||
Phentermine | lomamin | 2 | A | ||
Phentolamine | Regitine | 3 | B | ||
Phenylbutazone | Butazolidin | 4 | C* | ||
Phenylephrine | Isophrin, Neo-Synephrine | 3 | B | ||
Phenylpropanolamine | Propadrine | 3 | B | ||
Phenytoin | Dilantin | 4 | B | ||
Physostigmine | Eserine | 3 | A | ||
Picrotoxin | 1 | A | |||
Piminodine | Alvodine, Cimadon | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Pimobendan | 2 | B | |||
Pimozide | Orap | 2 | A | ||
Pinazepam | Domar | 2 | A | ||
Pindolol | Viskm | 3 | B | ||
Pipamperone | Dipiperon | 2 | A | ||
Pipecuronium | Arduan | 2 | A | ||
Pipequaline | 2 | A | |||
Piperacetazine | Psymod, Quide | 2 | A | ||
Piperocaine | Metycaine | 2 | A | ||
Pipotiazine | Lonseren, Piportil | 2 | A | ||
Pipradrol | Dataril, Gerondyl, etc. | 2 | A | ||
Piquindone | 2 | A | |||
Pirbuterol | Maxair | 3 | B | ||
Pirenzepine | Gastrozepin | 5 | C | ||
Piretanide | Arelix, Tauliz | 3 | B | ||
Piritramide | 1 | A | |||
Piroxicam | Feldene | 4 | B | ||
Plasma expanders (e.g. Bycerol; intravenous administration of albumin, dextran, hydroxyethyl starch and mannitol) | 3 | A | No legit use in the racehorse. Lacks FDA approval. | ||
Polyethylene glycol | 5 | D | |||
Polythiazide | Renese | 4 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Pramoxine | Tronothaine | 4 | C | ||
Prasterone (dehydroepiandrostero ne, DHEA, 3[BETA]hydroxyandrost-5-enl7-one) | 3 | B | Steroid - inactive endogenous steroid. | Endogenous AAS | |
Prazepam | Verstran, Centrax | 2 | A | ||
Prazosin | Minipress | 3 | B | ||
Prednisolone | Delta-Cortef etc. | 4 | C | ||
Prednisone | Meticorten, etc. | 4 | C | ||
Pregabalin | Lyrica | 3 | B | Gabapentanoid | |
Prilocaine | Citanest | 2 | B | ||
Primidone | Mysoline | 3 | B | ||
Probenecid | 4 | C | |||
Procainamide | Pronestyl | 4 | B | ||
Procaine | 3 | B | |||
Procaterol | Pro Air | 3 | A | ||
Prochlorperazine | Darbazine, Compazine | 2 | A | ||
Procyclidine | Kemadrin | 3 | B | ||
Promazine | Sparine | 3 | B | ||
Promethazine | Phenergan | 3 | B | ||
Propafenone | Rythmol | 4 | B | ||
Propanidid | 2 | A | |||
Propantheline | Pro-Banthine | 3 | B | ||
Proparacaine | Gphthaine | 4 | C |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Propentophylline | Karsivan | 3 | B | ||
Propiomazine | Largon | 2 | A | ||
Propionylpromazine | Tranvet | 2 | A | ||
Propiram | 2 | A | |||
Propofol | Diprivan, Disoprivan | 2 | A | ||
Propoxycaine | Ravocaine | 2 | A | ||
Propranolol | Inderal | 3 | B | ||
Propylhexedrine | Benzedrex | 4 | B | ||
Prostanazol | 3 | A | |||
Prothipendyl | Dominal | 2 | A | ||
Protokylol | Ventaire | 3 | A | ||
Protriptyline | Concordin, Triptil | 2 | A | ||
Proxibarbital | Axeen, Centralgol | 2 | A | ||
Pseudoephedrine | Cenafed, Novafed | 3 | B | ||
Pyridostigmine | Mestinon, Regonol | 3 | B | ||
Pyrilamine | Neoantergan, Equihist | 3 | B | ||
Pyrithyldione | Hybersufan, Sonodor | 2 | A | ||
Quazipam | Doral | 2 | A | ||
Quetiapine | Seroquel | 2 | A | ||
Quinapril, Quinaprilat | Accupril | 3 | A | ||
Quinbolone | 3 | A | |||
Quinidine | Quinidex, Quinicardine | 4 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Rabeprazole | Aciphex | 5 | D | ||
Racemethorphan | 2 | A | |||
Racemorphan | 2 | A | |||
Raclopride | 2 | A | |||
Ractopamine | Paylean | 2 | A | ||
Raloxifene | 3 | B | Estrogen effects, same classification as Testolactone on Human Olympic Guidelines -selective estrogen receptor modulators-SERMs. | Testolactone has B classification | |
Ramipril, metabolite Ramiprilat | Altace | 3 | A | ||
Ranitidine | Zantac | 5 | D | ||
Remifentanil | Ultiva | 1 | A | ||
Remoxipride | Roxiam | 2 | A | ||
Reserpine | Serpasil | 2 | B | ||
Rilmazafone | 2 | A | |||
Risperidone | 2 | A | |||
Ritanserin | 2 | A | |||
Ritodrine | Yutopar | 3 | B | ||
Rivastigmine | Exelon | 2 | A | ||
Rizatriptan | Maxalt | 3 | B | ||
Rocuronium | Zemuron | 2 | A | ||
Rofecoxib | Vioxx | 2 | B | ||
Romifidine | Sedivet | 3 | B |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Ropivacaine | Narcpin | 2 | A | ||
Roxadustat (FG-4592) | 1 | A | Erythropoietin Link - HIF prolyl-hydroxylase inhibitor and thereby increases endogenous production of erythropoietin, which stimulates production of hemoglobin and red blood cells. | Blood doping agent | |
Salicylamide | 4 | C | |||
Salicylate | 4 | C | |||
Salmeterol | 3 | B | |||
Scopolamine (Hyoscine) | Triptone | 4 | C | ||
Secobarbital (Quinalbarbitone) | Seconal | 2 | A | ||
Selective Androgen Receptor Modulators (SARMs) | 2 | A | |||
Selegiline | Eldepryl, Jumex, etc. | 2 | A | ||
Sertraline | Lustral, Zolcft | 2 | A | ||
Sibutramine | Meridia | 3 | B | ||
Sildenafil | Viagra | 3 | A | ||
Snake Venoms | 1 | A | |||
Somatrem | Protropin | 2 | A | ||
Somatropin | Nutropin | 2 | A | ||
Sotalol | Betapace, Sotacor | 3 | B | ||
Spiclomazine | 2 | A | |||
Spiperone | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Spirapril, metabolite Spiraprilat | Renomax | 3 | A | ||
Spironalactone | Aldactone | 4 | B | ||
Spironolactone | Diuretic | 3 | C | ||
Stanozolol | Winstrol-F | 3 | B | ||
Stenbolone | 3 | A | |||
Strychnine | 1 | A | |||
Succinylcholine | Sucostrin, Quelin, etc. | 2 | A | ||
Sufentanil | Sufenta | 1 | A | ||
Sulfasalazine | Azulfidine, Azaline | 4 | C | ||
Sulfondiethylmethane | 2 | A | |||
Sulfonmethane | 2 | A | |||
Sulforidazine | Incfal | 2 | A | ||
Sulindac | Clinoril | 3 | B | ||
Sulpiride | Aiglonyl, Sulpitil | 2 | A | ||
Suitopride | Barnetil | 2 | A | ||
Sumatriptan | Imitrex | 3 | B | ||
Synthetic cannabis | Spice, K2, Kronic | 1 | A | ||
Tadalasil | Cialis | 3 | A | ||
Talbutal | Lotusate | 2 | A | ||
Tamoxifen | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Estrogen receptor antagonist antineoplastic agent. | Testolactone has B classification |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Tandospirone | 2 | A | |||
Tapentadol | Nucynta | 1 | A | ||
TCO2 | 3 | B | |||
Telmisartin | Micardis | 3 | B | ||
Temazepam | Restoril | 2 | A | ||
Tenoxicam | Alganex, etc. | 3 | B | ||
Tepoxalin | 3 | B | |||
Terazosin | Hytrin | 3 | A | ||
Terbutaline | Brethine, Bricanyl | 3 | B | ||
Terfenadine | Seldane, Triludan | 4 | C | ||
Testolactone | Teslac | 3 | B | ||
Testolone | 2 | A | SARM | ||
Testosterone | 3 | B | |||
Tetrabenazine | Nitoman | 2 | A | ||
Tetracaine | Pontocaine | 2 | A | ||
Tetrahydrogestrinone | 3 | A | |||
Tetrahy drozoline | Tyzine | 4 | B | ||
Tetrazepam | Musaril, Myolastin | 2 | A | ||
THC (tetrahydrocannabinol)2 | Drug of human abuse | 1 | A | Drug of human abuse. | |
Thebaine | 2 | A | |||
Theobromine | 4 | B | |||
Theophylline | Aqualphyllin, etc. | 3 | B | ||
Thialbarbital | Kemithal | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Thiamylal | Surital | 2 | A | ||
Thiethylperazine | Torecan | 2 | A | ||
Thiopental | Pentothal | 2 | A | ||
Thiopropazate | Dartal | 2 | A | ||
Thioproperazine | Majeptil | 2 | A | ||
Thioridazine | Mellaril | 2 | A | ||
Thiosalicylate | 4 | B | |||
Thiothixene | Navane | 2 | A | ||
Thiphenamil | Trocinate | 4 | B | ||
Thyroxine and thyroid modulators/hormones, including but not limited to those containing T4 (tetraiodothyronine/thy roxine), T3 (triiodothyronine), or combinations thereof. | Levothyroxine | 3 | C | FDA approvad but has (limited) legitimate use in care of racehorses. | |
Tiapride | Italprid, Luxoben, etc. | 2 | A | ||
Tiaprofenic acid | Surgam | 3 | B | ||
Tibolone | 3 | A | Steroid - synthetic steroid. | AAS lacking FDA approval | |
Tildronate Sodium | Tildren | 3 | A | Bisphosphonate | |
Tiletamine | Component of Telazol | 2 | A | ||
Timiperone | Tolopelon | 2 | A | ||
Timolol | Blocardrm | 3 | B | ||
Tocainide | Tonocard | 4 | B | ||
Tofisopam | Grandaxain, Seriel | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Tolazoline | Priscoline | 3 | B | ||
Tolfenamic Acid | 4 | B | |||
Tolmetin | Tolectin | 3 | B | ||
Topirimate | Topamax | 2 | A | ||
Toremifene | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - Selective estrogen receptor modulator. | ||
Torsemide (Torasemide) | Demadex | 3 | A | ||
Tramadol | Ultram | 2 | B | ||
Trandolapril (and metabolite, trandolaprilat) | Tarka | 3 | B | ||
Tranexamic acid | 4 | C | |||
Tranylcypromine | Parnate | 2 | A | ||
Trazodone | Desyrel | 2 | A | ||
Trenbolone | Finoplix | 3 | B | ||
Tretoquinol | Inolin | 2 | A | ||
Triamcinolone | Vetalog, etc. | 4 | C | ||
Triamterene | Dyrenium | 4 | B | ||
Triazolam | Halcion | 2 | A | ||
Tribromethanol | 2 | A | |||
Tricaine methanesulfonate | Finquel | 2 | A | ||
Trichlormethiazide | Naqua, Naquasone | 4 | C | ||
Trichloroethanol | 2 | A | |||
Tricholoethylene | Trilene, Trimar | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Triclofos | Triclos | 2 | A | ||
Tridihexethyl | Pathilon | 4 | B | ||
Trifluomeprazine | Nortran | 2 | A | ||
Trifluoperazine | Stelazine | 2 | A | ||
Trifluperidol | Triperidol | 2 | A | ||
Triflupromazine | Vetame, Fesprin | 2 | A | ||
Trihexylphenidyl | Artane | 3 | A | ||
Trimeprazine | Temaril | 4 | B | ||
Trimetazidine | 3 | B | Hormone and Metabolic effects, same classification as Testolactone on Human Olympic Guidelines - a drug for angina pectoris, the first cytoprotective anti- ischemic agent. | ||
Trimethadione | Tridione | 3 | B | ||
Trimethaphan | Aifonad | 3 | A | ||
Trimipr amine | Surmontil | 2 | A | ||
Tripelennamine | PBZ | 3 | B | ||
Triprolidine | Actidil | 3 | B | ||
Trometamol (Also known as tris hydroxymethyl aminomethane [THAM]) | 3 | B | |||
Tubocurarine (Curare) | Metubin | 2 | A | ||
Tybamate | Benvil, Nospan, etc. | 2 | A | ||
Urethane | 2 | A | |||
Valdecoxib | 4 | B | Corrected to be consistent with all NSAIDS | ||
Valerenic acid | 3 | A | |||
Valnoctamide | Nirvanyl | 2 | A | ||
Valsartan | Diovan | 3 | B | ||
Vardenafil | Levitra | 3 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Vedaprofen | 4 | B | |||
Venlafaxine | Eflexor | 2 | A | ||
Veralipride | Acciona!, Veralipril | 2 | A | ||
Verapamil | Colon, Isoptin | 4 | B | ||
Vercuronium | Norcuron | 2 | A | ||
Viloxazine | Catatrol, Vivalan, etc. | 2 | A | ||
Vinbarbital | Delvinol | 2 | A | ||
Vinylbital | Cptanox, Speda | 2 | A | ||
Warfarin | Coumadin, Cotfarin | 5 | D | ||
Xylazine | Rompun, Bay Va 1470 | 3 | B | ||
Xylometazoline | Otrivin | 4 | B | ||
Yohimbine | 2 | B | |||
Zafirlukast | Accolate | 4 | c | ||
Zaleplon | Sonata | 2 | A | ||
Zeranol | Ralgro | 4 | C | ||
Ziconotide | 1 | A | |||
Zileuton | Zyflo | 4 | C | ||
Zilpaterol hydrochloride | Zilpaterol | 2 | A | ||
Ziprasidone | Geoden | 2 | A | ||
Zolazepam | 2 | A | |||
Zolmitriptan | Zomig | 3 | B | ||
Zolpidem | Ambien, Stilnox | 2 | A |
Drug/Substance | Trade Name(s) | Drug Class | Penalty Class | Special Notation | Note. |
Zomepirac | Zomax | 2 | B | ||
Zonisamide | Zonegran | 3 | B | ||
Zopiclone | Imovan | 2 | A | ||
Zotepine | Lodepin | 2 | A | ||
Zuclopenthixol | Ciatyl, Cesordinol | 2 | A |
UNIFORM CLASSIFICATION OF FOREIGN SUBSTANCES Version 14.4 (December, 2020)
PENALTY GUIDELINES
© ASSOCIATION OF RACING COMMISSIONERS INTERNATIONAL - 2020.
Association of Racing Commissioners International 2365 Harrodsburg Road, B-450, Lexington, Kentucky, United States www.arci.com
PENALTY CATEGORY "A"
The following are recommended penalties for violations due to the presence of a drug carrying a Category "A" penaltyand for violations of ARCTOll-015 and ARCT025-015: Prohibited Practices:
LICENSED TRAINER: | ||
1st Offense | 2nd LIFETIME offense in any jurisdiction | 3rdLIFETIME offense in any jurisdiction |
* Minimum one-year suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of a three-year suspension AND * Minimum fine of $10,000 or 10% of total purse (greater of the two) absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of $25,000 or 25% of purse (greater of the two). AND * May be referred to the Commission for any further action deemed necessary by the Commission. | * Minimum three-year suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of license revocation with no reapplication for a three-year period. AND * Minimum fine of $25,000 or 25% of total purse (greater of the two) absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of $50,000 or 50% purse (greater of the two). AND * May be referred to the Commission for any further action deemed necessary by the Commission. | * Minimum five-year suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of license revocation with no reapplication for a five-year period. AND Minimum fine of $50,000 or 50% of total purse (greater of the two) absent mitigating circumstances. The preence of aggravating factors could be used to impose a maximum of $100,000 or 100% purse (greater of the two). AND * May be referred to the Commission for any further action deemed necessary by the Commission. |
LICENSED OWNER: | ||
1st Offense | 2ndLIFETIME offense in owner's stable any jurisdiction | 3rdLIFETIME offense in owner's stable in any jurisdiction |
* Disqualification and loss of purse AND * Horse shall be placed on the Veterinarian's List for 180 days and must pass a commission-approved examination before becoming eligible to be entered. | * Disqualification and loss of purse AND *Horse shall be placed on the Veterinarian's List for 180 days and must pass a commission-approved examination before becoming eligible to be entered. | * Disqualification, loss of purse and $50,000 fine AND * Horse shall be placed on the Veterinarian's List for 180 days and must pass a commission-approved examination before becoming eligible to be entered. AND * Referral to the Commission with a recommendation of a suspension for a minimum of 90 days. |
PENALTY CATEGORY "B"
The following are recommended penalties for violations due to the presence of a drug carrying Category "B" penalty, for the detection of two or more NSAIDs in a plasma/serum and/or urine sample, the detection of two or more corticosteroids in a plasma/serum and/or urine sample subject to the provisions set forth in ARCI-011-020(E) and ARCI-025-020(E) and for violations of the established levels for total carbon dioxide:
Version 14.4, December 2020
LICENSED TRAINER: | ||
1st Offense | 2ndoffense (365-day period) in any jurisdiction | 3rd offense (365-day period) in any jurisdiction |
* Minimum 15-day suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of a 60-day suspension AND * Minimum fine of $500 absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum fine of $1,000. | * Minimum 30-day suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of a 180-day suspension AND * Minimum fine of $ 1,000 absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum fine of $2,500. | * Minimum 60-day suspension absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of a one-year suspension. * Minimum fine of $2,500 absent mitigating circumstances. The presence of aggravating factors could be used to impose a maximum of $5,000 or 5% purse (greater of the two). AND * May be referred to the Commission for any further action deemed necessary by the Commission. |
LICENSED OWNER: | ||
1stOffense | 2ndoffense (365-day period) in owner's stable any jurisdiction | 3rd offense (365-day period) in owner's stable in any jurisdiction |
* Disqualification and loss of purse [in the absence of mitigating circumstances]* AND * Horse must pass a commission-approved examination before becoming eligible to be entered. | * Disqualification and loss of purse [in the absence of mitigating circumstances] * AND * Horse must pass a commission-approved examination before becoming eligible to be entered. | * Disqualification, loss of purse, and in the absence of mitigating circumstances a $5,000 fine.* AND * Horse shall be placed on the Veterinarian's List for 45 days and must pass a commission-approved examination before becoming eligible to be entered. |
PENALTY CATEGORY "C"
The following are recommended penalties for violations due to the presence of a drug carrying a Category "C" penalty and overages for permitted NSAlDs and furosemide: (All concentrations are for measurements In serum or plasma.)
LICENSED TRAINER | Furosemide (>100 ng/ml) and/or no furosemide when identified as administered | Phenylbutazone (>0.3 meg/ml) Flunixin (> 5.0 ng/ml) Ketoprofen (> 2.0 ng/ml) and CLASS C Violations |
1stOffense (365-day period) in any jurisdiction | Minimum of a written warning to maximum fine of $500 | Minimum fine of $1,000 absent mitigating circumstances |
2nd Offense (365-day period) in any jurisdiction | Minimum of a written warning to maximum fine of $750 | Minimum fine of $1,500 and 15-day suspension absent mitigating circumstances |
3rd Offense (365-day period) in any jurisdiction | Minimum fine of $500 to a maximum fine of $1,000 | Minimum fine of $2,500 and 30-day suspension absent mitigating circumstances |
LICENSED OWNER | Furosemide (>100 ng/ml) and/or no furosemide when identified as administered | Phenylbutazone (>0.3 meg/ml) Flunixin (> 5.0 ng/ml) Ketoprofen (> 2.0 ng/ml) and CLASS C Violations |
1stOffense (365-day period) in any jurisdiction | Horse may be required to pass commission-approved examination before being eligible to run | Disqualification and loss of purse in the absence of mitigating circumstances. Horse must pass commission-approved examination before being eligible to run. |
2nd Offense (365-day period) in any jurisdiction | Horse may be required to pass commission-approved examination before being eligible to run | Disqualification and loss of purse in the absence of mitigating circumstances. If same horse, placed on veterinarian's list for 45 days, must pass commission-approved examination before being eligible to run |
3rd Offense (365-day period) in any jurisdiction | Disqualification and loss of purse. Horse must pass commission-approved examination before being eligible to run | Disqualification and loss of purse in the absence of mitigating circumstances. Minimum $5,000 fine. If same horse, placed on veterinarian's list for 60 days, must pass commission-approved examination before being eligible to run |
After a two-year period, if the licensee has had no further violations, any penalty due to an overage in the 2.0-5.0 category will be expunged from the licensee's record for penalty purposes.
PENALTY CATEGORY "D"
The recommended penalty for a violation involving a drug that carries a Category "D" penalty is a written warning to the trainer and owner. Multiple violations may result in fines and/or suspension.
MMV Point System
Multiple Medication Violation Model Rule. ARCI-011-020(B)(13)
Officials are advised to check a licensee's ARCI regulatory record to see if multiple medication violations should be considered as an aggravating factor in the determination of an appropriate penalty.
Penalty Class | Points If Controlled Therapeutic Substance | Points If Non-Controlled Substance |
Class A | N/A | 6 |
Class B | 2 | 4 |
Class C | 1/2 for first violation with an additional 1/2 point for each additional violation within 365 days1 | 1 for first violation with an additional 14 point for each additional violation within 365 days |
Class D | 0 | 0 |
1 Points for NSAID violations only apply when the primary threshold of the NSAID is exceeded. Points are not to be separately assigned for a stacking violation.
If the Stewards or Commission determine that the violation is due to environmental contamination, they may assign lesser or no points against the trainer based upon the specific facts of the case.
Points | Suspension in days |
5-5.5 | 15 to 30 |
6-8.5 | 30 to 60 |
9-10.5 | 90 to 180 |
11 or more | 180 to 360 |
MMV penalties are not a substitute for the current penalty system and are intended to be an additional uniform penalty when the licensee:
The Stewards and Commission shall consider aggravating and mitigating circumstances, including the trainer's prior record for medication violations, when determining the appropriate penalty for the underlying offense. The MMP is intended to be a separate and additional penalty for a pattern of violations.
Penalty Classification | Time to Expire |
A | 3 years |
B | 2 years |
C | 1 year |
In the case of a medication violation that results in a suspension, any points assessed expire on the anniversary date of the date the suspension is completed.
########
REVISIONS TO ARCI UNIFORM CLASSIFICATION GUIDELINES FOR FOREIGN SUBSTANCES
Version | Date | Drug/Substance | Notes |
14.2 | September 2020 | Medroxyprogesterone | Replaced methoxyprogesterone as probable typo |
14.2 | September 2020 | Medroxyprogesterone | Added as Drug Class 3, Penalty Class B. |
14.2 | September 2020 | Methoxyprogesterone | Removed as drug does not exist 14.2 September 2020 |
Methoxyprogesterone | Removed Asterisk Language on Permitted Nsaids | ||
"*If the trainer has not had more than one violation within the previous two years, the Stewards/Judges are encouraged to issue a warning in lieu of a fine provided the reported level is below 3.0 mcg/ml absent of aggravating factors." | |||
14.3 | September 2020 | Medroxyprogesterone | Moved to correct location alphabetically |
14.4 | December 2020 | Alpha pyrrolidinovalerophenon e Added as Drug Class 1, Penalty Class A | |
14.4 | December 2020 | Aripiprazole | Added as Drug Class 2, Penalty Class A |
14.4 | December 2020 | Arsenic | Added as Drug Class 3, Penalty Class B |
14.4 | December 2020 | Diisopropylamine | Added as Drug Class 2, Penalty Class B |
14.4 | December 2020 | Etofenamate | Added as Drug Class 4, Penalty Class B |
14.4 | December 2020 | Flufenamic Acid | Changed to Drug Class 4, Penalty B |
14.4 | December 2020 | Harpagoside | Added as Drug Class 4, Penalty B |
14.4 | December 2020 | Hypoxia-inducible factor (HIF) activators Changed from Drug Class 3, Penalty A to Drug Class 1, Penalty A | |
14.4 | December 2020 | Hypoxia-inducible factor (HIF) stabilizers (e.g. IOX-2) Added as Drug Class 1, Penalty A | |
14.4 | December 2020 | Molidustat | Added as Drug Class 1, Penalty A |
14.4 | December 2020 | Norethisterone(norethindi | one) Added as Drug Class 4, Penalty B |
14.4 | December 2020 | Oliceridine | Added as Drug Class 1, Penalty A |
14.4 | December 2020 | Oripavine | Added as Drug Class 2, Penalty A |
14.4 | December 2020 | Parecoxib | Added as Drug Class 4, Penalty B |
14.4 | December 2020 | Pregabalin | Added as Drug Class 3, Penalty B |
14.4 | December 2020 | Tapentadol | Added as Drug Class 1, Penalty A |
14.4 | December 2020 | Trometamol (Also known | as THAM) Added as Drug Class 3, Penalty B |
14.4 | December 2020 | Valdecoxib | Changed from Drug Class 2, Penalty B to Drug Class 4, Penalty B |
006.06.22 Ark. Code R. 008